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Abstract

PHENOLIC CONSTITUENTS FROM
GARCINIA INTERMEDIA AND RELATED SPECIES
by
Ulyana Muñoz Acuña
Adviser: Dr. Edward J. Kennelly
Antioxidants from plants scavenge free radicals and prevent reactive oxygen
species from having damaging effects in common ailments such as inflammation,
atherosclerosis, and Alzheimer’s disease. As part of our ongoing studies of antioxidants
from tropical edible fruits, we have studied Garcinia intermedia (Pittier) Hammel
[synonym: Rheedia edulis (Seem.) Planch. & Triana], native to Central America. In the
fruits the following compounds were identified: guttiferone A, guttiferone E,
xanthochymol, fukugetin, volkensiflavone and fukugeside. A new compound was
tentatively identified in the fruits of this species. The antioxidant activity of guttiferone A
in the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay was IC50 = 46 µM. The
antiproliferative effect of guttiferone A against colon cancer cells (HT-29) was IC50 =
15.8 µM.
A reversed-phase high-performance liquid chromatography (RP-HPLC) method
with diode array detection (DAD) was developed and validated to quantify seven major
phenolic compounds in eight Garcinia species from different geographic regions: G.
mangostana, G. xanthochymus, G. spicata, G. livingstonei, G. intermedia, G.
hombroniana, G. kola, and G. aristata. Garcina intermedia and G. mangostana had the
highest antioxidant activities.
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Chapter 1
Introduction

2

Fruits and vegetables are rich in essential antioxidant nutrients, including the provitamin β-carotene, and the vitamins C and E. Additional antioxidants, such as
polyphenols ingested through the daily diet increase the antioxidant capacity of plasma1,
and are an important source of protective compounds against the damaging effects of free
radicals.2 The benefits of certain non-nutritional antioxidants such as flavonoids have
been evaluated in several epidemiological studies.3,4,5 In particular, it has been shown that
a diet rich in fruits and vegetables significantly reduces the incidence and mortality rate
of cardiovascular diseases.6 A high intake of fruit and vegetables has been shown to have
protective effects against cancer.7, 8
Additional antioxidants, such as polyphenols present in the daily diet, increases
the antioxidant capacity of plasma.1 Polyphenols are an important source of protective
compounds against the damaging effects of free radicals.2 Free radicals are very reactive
in biological systems and are involved in producing reactive oxygen species (ROS) such
as O2•, ROO•, RO•, HO•, and NO•. ROS are naturally involved in cellular respiration,
phagocytosis and synthesis of biologically important compounds. However, they are also
damaging to lipids, proteins, and DNA and are formed in ailments such as cataracts,
Alzheimer’s disease, certain inflammatory conditions, and atherosclerosis.9
Plants in the Clusiaceae are a rich source of secondary metabolites with biological
activities. The major classes of secondary metabolites have been isolated from these
plants are: xanthones, coumarins and benzophenones. The Clusiaceae comprises 36
genera and around 1600 species,10 which are mainly distributed throughout the tropics,
although plants in a few genera are found in temperate regions.11 The presence of latex is
a common character of this family. The Clusiaceae is comprised of three subfamilies: the
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Kielmeyeroideae, the Hypericoideae, and the Clusioideae.11 The genus Garcinia includes
more than 250 species of dioecious trees and shrubs with pantropical distribution, with its
center of diversity in Southeast Asia and Madagascar. The floral characters exhibit a high
variability in this genus, thus taxonomical issues arise when studying these plants. A
broad concept of the genus, was supported by a recent molecular phylogenetic study,
including a geographically, morphologically, and taxonomically comprehensive
sampling.12 The previously segregated genera Rheedia, Ochrocarpus, Pentaphalangium
and Tripetalum are now accepted as part of genus Garcinia (Table 1.1), although in this
thesis, names in Rheedia are sometimes used as reported in the literature.
Table 1.1. Classification of genera in the Clusiaceae.11
I.
Subfamily
Kielmeyeroideae Engler
A. Tribe Calophylleae Choisy
Neotatea Maguire
Marila Swartz
Mahurea Aublet
Kielmeyera Martius
Caraipa Aublet
Haploclathra Bentham
Poeciloneuron Beddome
Mesua L.
Kayea Wall.
Mammea L.
Calophyllum L.
B. Tribe Endodesmieae Engler
Endodesmia Bentham
Lebrunia Staner

II.
Subfamily
Hypericoideae Engler
A. Tribe Vismieae Choisy
Vismia Vand.
Harungana Lamarck
B. Tribe Hypericeae Choisy
Hypericum L.
Lianthus N. Robson
Triadenum Raf.
Thornea Breedlove &
McClintock
Santomasia N. Robson
C. Tribe Cratoxyleae Bentham
Cratoxylum Blume
Eliea Cambess.

III.
Subfamily
Clusioideae Engler
A. Tribe Clusielleae (P.F.Stevens)
Clusiella Planch. & Triana
B. Tribe Clusieae Choisy
Clusia L.
Dystovomita D’Arcy
Tovomita Aublet
Chrysochlamys Poepp.
Tovomitidium Ducke
C. Tribe Garcinieae Choisy
Garcinia L.
Pentaphalangium Warb.
Rheedia L.
Tripetalum K. Schum.
Allanblackia Oliver
Ochrocarpus Thouars.
D. Tribe Symphonieae Choisy
Pentadesma Sabine
Moronobea Aublet
Platonia Martius
Montrouziera Planch. & Triana
Lorostemon Ducke
Thysanostemon Maguire
Symphonia L. f.
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The antioxidant capacity of plants is mainly attributed to the phenolic
constituents.13 Phenolic compounds are antioxidants found in plants, and can be found in
agricultural crops such as apples, grapes, blackberries, and strawberries.14 In my research,
the phenolic content of edible Garcinia fruits (Clusiaceae) has been studied. Products
containing G. mangostana are commonly sold as dietary supplements in the US. This
phytochemical investigation included eight Garcinia species from different geographical
origins. In this study, the main objectives were; [i] a literature review of the bioactivity of
polyisoprenylated benzophenones15, [ii] identification of new polyisoprenylated
benzophenones isolated from Garcinia intermedia, [iii] identification and quantification
of polyisoprenylated benzophenones and biflavonoids in eight Garcinia species, [iv] in
vitro investigation of the antioxidant and antiproliferative effects against colon cancer
cells of guttiferone A.

5

Chapter 2
Polyisoprenylated Benzophenones from Clusiaceae: Potential Drugs and Lead
Compounds
A Review* 15

*This chapter has been published previously.
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2.1. Introduction
Natural products of plants origin are important sources of new chemical
compounds leading to the future discovery of new drugs. In the areas of cancer
chemotherapies, anti-inflammatory drugs, antibacterial drugs, and antiparasitic drugs,
there is demand for new, more effective treatments.16 Herein, we examine the bioactivity
of the polyisoprenylated benzophenones isolated from plants of the Clusiaceae family.
The Clusiaceae family is a rich source of secondary metabolites, including the widely
used medicinal herb Hypericum perforatum L., commonly known as St. John’s wort,
which has been traditionally used for its antidepressant activity.17 Four major classes of
compounds are found in the Cluisaceae family: xanthones, coumarins, biflavonoids, and
benzophenones.
The polyisoprenylated benzophenones are major intermediates in the biosynthetic
pathway of xanthones, and have been rarely reported to occur outside the Clusiaceae
family.18 The benzophenones are non-polar phenolic compounds, with increased
hydrophobicity as a function of the number of prenyl functional groups attached. Most
polyprenylated benzophenones isolated from plants have the bicyclo[3.3.1]-nonane-2,4,9trione core structure linked to a 13,14-dihydroxy substituted phenyl ring (Fig. 1).19 This
planar structure, with polar carbonyl and hydroxyl groups, can be simple or substituted
by isoprene units.
Benzophenones

exhibit

cytotoxic,20

antimicrobial,21,22

antiviral,23

and

antioxidant24, 25, 26 activities. The most cited natural benzophenones in the literature are
garcinol (1) and xanthochymol (2) (Tables 1 and 2). These compounds are cytotoxic in
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several cancer cell lines including colon,25, 27, 28 breast,28, 29, 30 ovarian,31, 32, 33 oral,

34, 35

and leukemia.36, 37
Polyisoprenylated benzophenones induce apoptosis and arrest the cell-cycle in
sub G1-phase

38

; however, the mechanism of action by which benzophenones in induce

apoptosis and exert cytotoxic effects is still under investigation.
Several groups have independently investigated the mechanism of action of
polyisoprenylated

benzophenones.34,37,38

Although

studies

have

shown

that

polyisoprenylated benzophenones bind to microtubules and inhibit the disassembly of
tubulin during cell division, our findings show38 that benzophenones increase the activity
of caspase-3, possibly inducing apoptosis.38 Benzophenone action has the same
mechanism as that of paclitaxel, but at a lower potency. Several studies suggest that
benzophenones increase the activity of caspase-3, inducing apoptosis.27,

37, 38

Besides

inhibition of microtubule disassembly,34 other possible mechanisms of action against
cancer cells have been presented: inhibition of microtubule disassembly,34 inhibition of
histone acetyl tranferase activity,39 inhibition of protease activity,40 inhibition of kinase
activity,36 or directly acting as prooxidant damaging DNA.41
We are not aware of any review publications on benzophenones from natural
sources. Thus, this work presents, to our knowledge, the first summary of
polyisoprenylated benzophenones as secondary metabolites found mainly in Clusiaceae
family.
This review is based primarily on Internet research of the literature using different
electronic databases such as MEDLINE, Science-Direct, Basic-Biosis, and Chemical
Abstracts. The following search terms, without language restrictions, were used during
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the research: polyisoprenylated benzophenones, garcinol, xanthochymol, Clusiaceae and
benzophenones, Garcinia sp. and benzophenones, antioxidant activity, cytotoxicity,
antiviral, anti-HIV, antimicrobial, and antiinflammatory properties of benzophenones.
Additionally, an advanced search was performed to select only the articles that involve
benzophenones isolated from natural sources. Searches were performed over the time
period, January through May 2009.
2.2. Chemical structure
The core of a polyisoprenylated benzophenone is composed of a bicyclo[3.3.1]nonane-2,4,9-trione structure, linked to a 3,4-dihydroxybenzoyl moiety (Fig. 1).19 The
benzoyl ring is usually hydroxylated, in position ortho and para. The 3-methyl-2-butenyl
groups or prenyl groups are attached at carbon C-1, C-5, and C-7 of the bridged bicyclic
structure (Fig. 1). There are examples, such as isoxanthochymol (3) or cambogin (4),
where the isoprenyl substituting unit at C-5 undergoes cyclization. During cyclization,
the oleofinic bond undergoes epoxidation, and subsequently forms a bond with the
oxygen on carbon C-4, forming an additional pyran ring.
These polyisoprenylated benzophenones commonly occur as tautomeric pairs.
That is, the diketone easily forms hydroxyl groups that are formed at C-4 and C-1 in the
enolized diketone.

It has been suggested that the enolic hydroxyl group in the -

hydroxy-,-unsaturated ketone plays an important role concerning bioactivity.41 Ketoenol tautomerism has been reported for curcumin, whose structure has certain similarities
to benzophenones.42, 43
The position C-7 constitutes a chiral center forming stereoisomers. Thus the
isopentenyl substituent at C-7 is either in an equatorial or in an axial position. The
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relative configuration of benzophenone compounds can be deduced from NOE and
ROESY spectra and the coupling constant when analyzing these compounds by nuclear
magnetic resonance (NMR).44
In summary, the planar ring structure of benzophenones is highly conjugated,
with delocalized electrons and strongly polarized carbonyl and hydroxyl groups. The UV
spectrum shows absorption bands caused by an aromatic chromophore at 282 and at 234
nm, due to a conjugated carbonyl group.
2.3. Clusiaceae genera
Most of the polyisoprenylated benzophenones included in this review were
isolated from the genus Garcinia L. The genus Garcinia (Subfamily: Clusioideae, tribe
Garciniae) is distributed throughout tropical regions of the world. The genus Garcinia
comprises 200 species, and some are used for their latex and resins. The fruits are edible
and many have medicinal uses. Benzophenones isolated from seven genera, have been
assayed for cytotoxicity: Garcinia, Rheedia, Hypericum, Clusia, Ochrocarpus, Tovomita,
and Vismia (Table 1). Antibacterial benzophenones have been isolated from the seven
following genera: Garcinia, Rheedia, Hypericum, Clusia, Allanblackia, Symphonia, and
Moronobea (Table 2). Polyisoprenylated benzophenones are rarely found outside the
Clusiaceae family. However, structurally similar isoprenylated benzophenones with
cytotoxic activity have been isolated from Cudrania in the Moraceae family45 as well as
from other natural sources.46
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2.4. Effects on Cancer Cells in vitro
2.4.1. Cytotoxicity
Plants are an important source of cytotoxic compounds for anticancer therapies. In
total, twenty-six studies reported cytotoxic activity for polyisoprenylated benzophenones
isolated from plants in the Clusiaceae family (Table 1). Most of these studies were
performed using human leukemia (HL-60) and oral carcinoma (KB) cells. Although
benzophenones show relatively potent cytotoxic effects, paclitaxel showed a hundredfold
more effective cytotoxic activity than the tested benzophenones.20,34,47 Paclitaxel, a
cytotoxic compound originally isolated from Taxus brevifolia Nutt., was used as a
positive control in three studies, comparing effects of polyisoprenylated benzophenones
to that of paclitaxel (Table 1).20, 34, 47
In

a

comprehensive

cytotoxic

study,20

both

xanthochymol

(2)

and

isoxanthochymol (3) were tested against three different cancer cell lines, including breast
(MCF-7), liver (WRL-68), and colon (COLO-320-DM) cancer cells. The activities of
paclitaxel were tested in each of the cell lines: IC50= 0.005 M (MCF-7), IC50= 0.054 M
(WRL-68), and IC50= 0.01 M (COLO-320-DM).20 Xanthochymol (2) displayed
IC50=0.457 M (MCF-7), IC50= 2.52 M (WRL-68), IC50= 0.62 M (COLO-320-DM).20
The IC50 values for isoxanthochymol (3) in each of the above mentioned cell lines were:
2.85 M (MCF-7), 15.52 M (WRL-68), and 4.85 M (COLO-320-DM).20
Kumar et al. (2007) suggested that xanthochymol (2) is more effective than
isoxanthochymol (3) particularly against breast cancer cells MCF-7 and liver cancer cells
WRL-68, although it is a hundredfold less effective than paclitaxel.20
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Xanthochymol (2) was screened for cytotoxic activity in four different studies
(Table 1), and it was more active against breast cancer cells (MCF-7) than against the
other tested cell lines (IC50= 0.475 M), while isoxanthochymol (3) showed highest
activity (IC50= 0.62 M) against colon cancer cells (COLO-320-DM).48
Guttiferone A (5) displayed activity against A2780 human ovarian cancer cell
lines, IC50 = 6.8 g/ml.33 The effect was a thousand times weaker than the activity of the
control actinomycin D, IC50 = 0.003 g/ml.33 Guttiferone I (6) and J (7) showed
inhibitory activity in KB oral carcinoma cells, with an IC50 = 4.70 g/ml and an IC50 = 5.0
g/ml, this in comparison with the control taxotere, IC50 = 0.37 ng/ml.47 Nevertheless,
isoprenylated benzophenones from the Clusiaceae family definitely displayed cytotoxic
activities, although consistently lower than the positive controls, paclitaxel and
actinomycin D.
Xanthochymol (2) was the most cytotoxic of all the tested polyisoprenylated
benzophenones, particularly against MCF-7 cells, (IC50= 0.475 M).20 Nemorosone (8)
was the second most active, and had a cytotoxic activity of IC50= 1.5  0.08 g/ml
against HEPT-1 larynx cancer cells. In leukemia cells nemorosone (8) showed activity in
the ranges of IC50 = 2.10 g/ml to IC50 = 3.10 g/ml36 (Table 1). Vismiaguianone D (9)
was the third most active compound reported among the studied benzophenones,
particularly against oral carcinoma cells KB, IC50 = 2.40  0.9 g/ml.35
Oblongifolin C (9) from Garcinia yunnanensis Hu showed activity against
cervical HeLa-C3 cells, and apoptosis was induced after 72 h of incubation with a
concentration of 15 M.49 Tovophenone A (11) was isolated from Tovomita
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brevistaminea Engl., and was found to be inactive against KB cells; the effective
concentration (EC50) was 10 g/ml.50
2.4.2. Garcinol
The most frequently tested polyisoprenylated compound was garcinol (1), which
showed cytotoxic effects in five studies (Table 1). Garcinol is the trivial name of
camboginol (1),23 as they have the same stereochemical structure.23 Camboginol (1) was
originally isolated from G. cambogia Desr. and its stereochemistry has been identified
and reported.51
Garcinol (1) was included in five cytotoxicity studies, and the activity and
inhibitory concentration (IC50) ranged from 5 to 21.4 M

37

(Table 1). Treatment with

garcinol caused the reduction of the mitochondrial transmembrane potential, an important
evidence of apoptotic effects.37 Furthermore, it was shown that garcinol (1) increased the
activity of caspase-3 during apoptosis.37 In another study, the activity of caspase-3
increased when tested at 2 and 6 hours.27
Garcinol (1) was also tested against HL-60 leukemia cells.27, 37, 52, 53 Treatment of
leukemia cells with garcinol (1), isoxanthochymol (3), and xanthochymol (2) was shown
to cause apoptosis, mediated by caspase-3.37 However, no activation of caspase-8 was
found in this study.37 In this study, the effects of garcinol (1) on the cell cycle wpould
consist in targeting the mitochondria in the early phase of the apoptotic process.
Furthermore, another study shows that garcinol induces apoptosis and increases caspase3 activity in a dose-dependent manner.43
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To date, there is no clear evidence concerning the mechanisms through which
garcinol and other isoprenylated compounds cause apoptosis and cytotoxic effects on
cancer cells.
2.4.3. Inhibiton of histone acetyl transferases
In a systematic approach to indentify compounds from plants that have effect on
histone acetyl transferases (HAT), it was found that garcinol (1), isolated from the fruit
rind of Garcinia indica Choisy, was a potent inhibitor of HAT, specifically p300 and
PCAF, IC50 = 7 M and IC50 = 5 M.39 The inhibiting effects on histone
acetyltransferases, p300 and PCAF for garcinol (1) led to apoptosis in these HeLa cells,
suggesting that HAT inhibition might be the possible mechanism of action through which
polyisoprenylated benzophenones from plants exert cytotoxic effects in different
cancerous cell lines.
The balance between acetylation and deacetylation of histones is important during
cell growth and differentiation. Acetylation of histones plays an important role in DNA
and protein interaction during transcription. Notably, garcinol (1) has been shown to be a
specific inhibitor of acetylation. The concentration range of garcinol tested was between
1 M and 100 M.39 The HAT inhibiting activity of garcinol (1) was investigated using
HeLa cells and recombinant HAT p300 and PCAF.39 A microarray analysis showed that
transcription was globally repressed. Further evidence showed that garcinol (1)
competitively inhibited the activity of both p300 and PCAF, competing with histones for
the active site of the enzyme. Very few HAT inhibitors have been reported, thus garcinol
(1), inhibiting HAT and transcription, is a candidate molecule to be tested for future
cancer therapies.
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2.4.4. Gene expression analysis
In our own studies,25, 38 xanthochymol (2) isolated from Garcinia xanthochymus
Hook.f. showed cytotoxic activity against colon cancer cells. The reported inhibitory
concentration against SW-480 cells for xanthochymol (2) was IC50 = 8.3 M and for
guttiferone E (12) it was IC50 = 7.5 M.25 Xanthochymol (2) showed significant
cytotoxicity against cell lines HCT-116 and HT-29 derived from colon cancer tissues,
IC50 = 10 M and IC50 = 15 M.25 In addition to xanthochymol (2) and guttiferone E (12),
guttiferone H (13) was isolated by our group and was shown to display an IC50 = 12 M
against SW-480 cancer cells and an IC50 = 9.0 M against HCT-116.25, 38 We found that
caspase-3 activation occurred after 24 h.38 These findings are supported by similar results
reported by Matsumoto et al.37 and Hong et al.42 We found no significant activation of
caspase-8 and 9 in HCT-116 and HT-29 cells.38
The proapoptotic effect of xanthochymol (2), guttiferone E (12), and guttiferone
H (13) in HCT116 and HT29 cells was examined more closely by microarray analysis.38
The effect on gene expression in HCT116 and HT29 cells was studied at IC50
concentration for 18, 24, and 48 hours. Poly(A)-RNA was extracted from cells used in
these experiments and used as templates to synthesize biotin-labeled cDNA to perform
the hybridization and gene array analysis. Gene tree cluster analysis showed that array
samples clustered into three main groups, and few genes were induced.
Genes involved in the stress response of the endoplasmatic reticulum were upregulated namely: X-box binding protein 1 (XBP1); activating transcription factor 4
(ATF4); and DNA-damage inducible transcript 3 (DDIT3/CHOP), possibly a response to
unfolded proteins and possibly affecting the progression through the cell cycle leading to
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cell cycle arrest.38 The cellular energy stress response gene, DNA-damage inducible
transcript 4 (DDIT4/REDD1) was highly induced by treatment. DDIT4/REDD1 is a
transducer that inhibits the mammalian target of rapamycin (mTOR) pathway. In
addition, our results also indicated that the mTOR survival pathway was inhibited in
treated cells.38 The mTOR pathway plays an important role during cellular stress
responses, cell growth and survival and it is dysregulated by various oncogenic events. It
was found that curcumin also affects the mTOR pathway.54
It seems that both the polyisoprenylated benzophenones and curcumin might
target phosphatases regulating the phosphoinositide-3 kinase/Akt/mTOR pathway and
have cytotoxic effect in cancer cells. Curcumin was found to activate protein phosphatase
2A (PP2A) and calyculin-A in treated cancer cells. This led to dephosphorylation and
inhibition of Akt/PKB protein kinase B and mTOR mediators. This was followed by
inhibition of down-stream mediators of the pathway such as glycogen synthase kinase
(GSK-3). Consequently, expression of proteins essential for cell survival and
proliferation of a cancer cell, such as cyclin D1, was suppressed.54 However, the specific
phosphatases activated by curcumin need to be further investigated.54 It remains to be
determined if histone deacetylase (HDAC) inhibitor alters the activity of Akt protein
kinase as well, through the protein phosphatase complex (PP1).55
2.4.5. Protease inhibition
Guttiferone A has a planar structure with strongly polarized groups which interact
with serine proteases.40 The X-ray crystal structure confirmed that guttiferone A (5)
bound to the active site of serine proteases. The phenyl ring and the prenyl groups present
in guttiferone A (5) form van der Waals interactions with the catalytic site of the enzyme:
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the hydroxyl moieties donate or accept hydrogen from the amino acids of the protein,
thus binding more tightly to the residus in volved in the proteolytic activity of the
enzyme. Thus hydroxylation of the bridge carbon in the benzophenone activity tautomere
seems to be important for the activity of benzophenones.40,56 These findings suggest that
isoprenylated benzophenones such as garcinol (1) might bind to proteases, indicating that
both antiviral and cytotoxic effects caused by guttiferone-type compounds take place
through binding and inhibiting proteases.40
2.4.6. Akt/PKB kinase inhibition
Nemorosone (8) from Clusia rosea Jacq. was found to have antiproliferative and
proapoptotic effects in Jurkat and K-562 human leukemia cells.36 Apoptosis was induced
within 4 hours after treatment. Later on, an increase of sub G0/G1 cell population was
observed, and it appears that nemorosone (8) prevents the progression G1/S transition in
cells, as well as altering the controllers of G2/M progression. These line of evidence lead
to conclude that Akt/PKB kinase appears to be inhibited by nemorosone (8), making this
enzyme is another likely physiological by causing apoptosis.
Akt/PKB is a serine/threonine protein kinase that plays a fundamental role in
carcinogenesis. As a response to damaged DNA, Akt/PKB does not activate GSK-3.
Further, the oncogene c-Myb was down-regulated in nemorosone-treated Jurkat and K562 cells.
It was shown that nemorosone (8) disrupted the cell cycle in a dose dependent
manner. Western blot analysis showed that cyclin D1 and E were down-regulated.36
Moreover, the cyclin-dependant kinase 1 (Cdk1/cdc2) was down-regulated and
dephosphorylated in cells treated with (8). According to these findings and in order to
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define more closely which pathways are affected br nemorosone during G1/S progression
leading to apoptosis, it will be necessary to perform further studies on the physiological
status of inhibitors of cell cycle regulators.
2.4.7. Prooxidant activity and DNA breakage
Garcinielliptone (14) was tested against lines derived from breast cancer cells,
such as MCF-7. The effect of treatment in MCF-7 cells was observed using fluorescence
microscopy. Nuclear fragmentation were observed to occur in a dose dependent manner.
Flow cytometry analysis showed accumulation of sub-G1 DNA of apoptotic cells.
Further, it was shown that garcinielliptone had a prooxidant effect in the presence of
Cu(II). Nevertheless, prooxidants such as Cu(II) might not be commonly found unbound
in the nucleus. Garcinielliptone-generated ROS, caused the breakage of DNA and,
subsequently cell death.28, 41
2.4.8. SAR studies
With respect to vismiaguinones, the contrary to what other studies have
suggested, the number of prenylated substituents in the structure, did not affect
cytotoxicity as significantly as other substituents did. On the other hand, the number of
hydroxylations, the presence of an additional phenyl group and -bonds, significantly
increase the cytotoxicity of vismiaguinones.35 Vismiaguianone A (15) through D (9)
isolated from Vismia guianensis (Aubl.) Choisy, were tested against oral carcinoma
cells.35 Vismiaguianones A (15), B (16), and C (17) have displayed a lower cytotoxicity
than that of vismiaguianones D (9) and E (18) in the KB cell line.35 The vismiaguianones
A (15) through C (17) have three hydroxyl groups, while vismiaguianone D (9) and E
(18) have two.35 Only vismiguianones D (9) and E (18) have an additional phenyl ring,
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and only D (9) and E (18) were the most active compounds.35 Vismiaguianone D (9)
showed the highest activity and had a four-ring structure, with three additional -bonds
and an ester function, possibly leading to higher cytotoxic activity.35 Thus the number of
hydroxy-groups and double bonds correlated with higher cytotoxic activity. All the tested
vismiaguianones had one prenyl substituting group,35 indicating that the number of
hydroxyl groups and double bonds in the isoprenylated benzophenone are more important
than the number of prenyl-substituent groups, in this particular case, against KB cell
lines.
2.4.9. Synthetic analogues and cytotoxicity
Synthetic benzophenones were modified and tested on P388 leukemia cells and
on PC-6 human lung carcinoma cells. Among the synthetic benzophenone derivatives
tested for cytotoxicity, the nitrobenzophenones showed a potent cytotoxic activity both in
vitro and in vivo.57 Whereas the aminobenzophenones showed weak activity. Fluorouracil
(5-FU) was used as a control.57 When functional groups were oxidized the nitroketone of
a modified benzophenone was more active than the corresponding nitro-alcohol.57 Amide
derivatives were only weakly active.57 Among the nitrobenzophenones, the morpholino
derivative (19) showed higher cytotoxicity and growth inhibition (GI50= 16.8 ng/ml)
effects in vitro against P388 leukemia cells than those obtained with the positive control
5-FU (GI50= 55 ng/ml).57 The carbonyl and nitro moieties of the synthetic analogues were
considered to be essential for cytotoxic activity in vitro; however, in vivo, in CDF1 mice
inoculated with P388 cells, it was the thiomorpholino derivative which increased the life
span (ILS) by 35%, at a dose of 2 x 206 mg/kg, although the effect was not as potent as
5-FU (82% ILS) at 2 x 100 mg/kg. Chlorination of nitrobenzophenones, in particular the
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morpholino benzophenones, showed the highest cytotoxic activity. Further studies of
animals treated with this compound, however, did not show an increase in the ILS of
P388 cells inoculated in mice.57 In conclusion, given their potent cytotoxic activity and
low toxicity the synthetic nitrobenzophenones, are promising cytotoxic compounds.57
2.5. Effects on Cancer cells in vivo
In an animal study, male F344 rats were fed with garcinol (1) to to test the
hypothesis

that

dietary

garcinol

(1)

suppresses

chemically

induced

colon

carcinogenesis.58 Oral administration of (1) showed no toxic effect on normal animal
growth and was well tolerated with no adverse effects reported. Further in the same study
it was shown that the dietary administration of (1) significantly inhibited and reduced the
frequency of the chemically induced aberrant crypt foci (ACF), induced by
azoxymethane. These findings suggested that dietary garcinol (1) suppresses chemically
induced colon carcinogenesis in F344 rats as shown by reduced the frequency of ACF: 72
 15 (26% reduction, P  0.01) at a dose of 0.01% and 58  8 (40% reduction, P  0.001)
at a dose of 0.05%.58 The results from this study58 suggested that the chemopreventive
effects of (1) on colon tumorogenesis were possibly due to the suppression of the
production of NO and O2-. The levels of O2- and NO were induced by 12-Otetradecanoylphorbol-13-acetate (TPA) treatment in differentiated human promyelocytic
HL-60 cells and lipopolysaccharide (LPS) and interferon (IFN)--treated mouse
macrophage RAW 264.7 cells.58 In the same study, western blot analysis showed the
suppression of inducible nitric oxide synthase (iNOS) protein expression as well as
cyclooxygenase-2 (COX-2) protein expression. Although the mechanism through which
(1) reduced the expression of these proteins was not presented in the above mentioned
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experiments, the role of iNOS and COX-2 in inflammation and as enhancers during
carcinogenesis in colon tissue was discussed and further studies are investigating the
chemopreventive potential of (1).
2.6. Antimicrobial activity
2.6.1. Antibacterial activity
Antibiotic resistant bacterial strains cause severe infection worldwide. The
majority of new potent antibiotics are derived from natural products. Polyisoprenylated
benzophenones from plants in the Clusiaceae family have significant antimicrobial
activities (Table 2). In particular, two studies show that polyisoprenylated benzophenones
have potent antibacterial activity against antibiotic resistant strains.22, 59
Five benzophenone compounds isolated from G. pupurea Roxb. and G.
subelliptica Merr. were tested against methicillin resistant Staphylococcus aureus
(MRSA).59 Antibacterial activities of the benzophenone derivatives garcinol (1),
isogarcinol (20), xanthochymol (2), isoxanthochymol (3), and cycloxanthochymol (21)
were evaluated, displaying a minimum inhibitory concentration (MIC) range from 3.13 to
12.5 g/ml for benzophenones mentioned above (Table 2).59 Xanthochymol (2) was the
most active with a MIC = 3.13-12.5 g/ml (Table 2). Garcinol (1) showed a MIC = 6.25
g/ml. The antibacterial activity of garcinol (1) was nearly equal to that of the positive
control vancomycin (MIC = 6.25 g/ml), which is commonly used against Gram-positive
bacteria.59 In addition, garcinol (1) from G. bacana Miq. showed antimicrobial effects
against S. aureus, MIC = 16 g/ml.60 No synergistic effect was detected for
isoxanthochymol (3) and cycloxanthochymol (21).59
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The antimicrobial effects of 7-epiclusianone (22), isolated from the root of
Hypericum sampsonii Hance was tested against MRSA (SA-1199B).22 This particular
bacterial strain overexpressed the NorA efflux protein, considered the major drug pump
responsible for antibiotic resistance. It was shown that 7-epiclusianone (22) had a MIC =
7.3 M. The antibacterial activity of 7-epiclusianone (22) was compared to the activity of
norfloxacin (MIC= 100 M). These results confirm that 7-epiclusianone (22) is a potent
antimicrobial agent.
The antimicrobial activity of 7-epiclusianone (22) was further confirmed by
another study, where the source of the phytochemical was obtained the peel and seed
extracts of Rheedia brasiliensis (Mart.) Planch. & Triana (synonym: Garcinia
brasiliensis) and was tested against Streptococcus mutans.61 In this study, 7epiclusianone (22) showed an MIC of 1.25-2.5 g/ml,61 and the control clorhexidine had
an MIC = 1-2 g/ml.
Two guttiferone-type compounds, guttiferone I (6) and isoxanthochymol (3) from
Garcinia smeathmannii (Planch. & Triana) Oliv. were tested against Gram-negative and
Gram-positive bacteria.21 Guttiferone I (6) showed a potent activity against Gramnegative bacterial strains, while isoxanthochymol (3), with a cyclic ring, was the most
active against Gram-positive strains, mainly Bacillus cereus and B. stearothermophilus.
Guttiferone I (6) showed potent activity against B. megatorium, a Gram-positive strain
(IC50= 0.61 g/ml). It was noted that guttiferone I (6) showed higher activity than the
control, genthamycin (IC50= 2.44 g/ml) against all tested strains in this particular study
(Table 2).
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The extracts from Clusiaceae plants had a more pronounced activity against the
tested Gram-positive bacterial strains, than against the Gram-negative bacteria. The
extracts of Garcinia cowa Roxb. and G. pedunculata Roxb. were tested against Bacillus
cereus, B. coagulans, B. subtilis, S. aureus and Escherichia coli.62 The chloroform extract
of the fruit rinds of G. cowa were active against B. cereus (MIC= 15 g/ml), B.
coagulans (MIC=25 g/ml), B. subtilis (MIC= 25 g/ml), and S. aureus (MIC= 30
g/ml).
In another study both chamone I (23) and nemorosone (8) isolated from the
tropical species Clusia grandiflora Splitg. showed potent antibacterial activity against
honey-bee pathogens. Nemorosone (8) showed an activity against Paenibacillus larvae
(total inhibition 19.5  1.6 mm) and Paenibacillus alvei (total inhibition 2.3  9 mm).
Chamone I (23) also had activity against the above mentioned pathogens, (total inhibition
19.7  0.3 mm) and (total inhibition 10  0.6 mm).63 Plants generally produce secondary
metabolites as a defense mechanism; however it is possible that plants in the Clusiaceae
family produce isoprenylated benzophenones as pollination rewards and that pollinating
bees use the latex with these antibacterial substances for protection against pathogens.
Nemorosone (8) has been identified and described as one of the major constituents of the
Cuban propolis, coming from the floral resin of Clusia rosea Jacq.64, 65
Potent antibacterial benzophenones have been isolated from natural sources other
than plants, most notably from fungi.46, 66, 67 Pestalone (24) was obtained from a mixed
fermentation of a marine fungus, a marine deuteromycetes (Pestalotia sp. strain CNL365,) and an unidentified antibiotic resistant marine bacterium.66 Pestalone (24) showed
potent activity against MRSA (MIC = 37 ng/ml) as well as against vancomycin-resistant
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Enterococcus faecium (MIC = 78 ng/ml).66 Benzophenone dimer, microsphaerin D (25)
was obtained from the anamorphic fungus Microsphaeropsis strains F2076 and F2078.67
Microsphaerin D (25) showed activity against MRSA, IC90 = 1 M.67 Pestalachloride A,
(26) obtained from a plant endophytic fungus, showed activity against plant pathogenic
fungi, specifically against F. culmorum (IC50 = 0.89 M).46
2.6.2. Antiviral activity
Activity against the human immunodeficiency virus-1 (HIV-1) was first reported
for the polyisoprenylated benzophenone guttiferone A (5), subsequently, new lead
molecules for antiviral drug treatment have been isolated.68 The identification of
guttiferone A (5) was followed by the isolation and characterization of guttiferone F (27),
which exhibited partial cytoprotection against HIV-1 in vitro (EC50 = 23 g/ml) as well as
cytotoxicity (IC50 = 82 g/ml). Additional polyisoprenylated benzophenones from natural
sources such as, garciosaphenone A (28) showed anti-HIV-1 activities (IC50 < 7.8
g/ml).69 In addition, vismiaphenone D (29) showed HIV-inhibitory activity.70
Garciosaphenone A, a new digeranylbenzophenone from G. speciosa Wall. showed
activity against HIV-1 reverse transcriptase, IC50 = 23.9 g/ml.69
Since these findings in natural products research, several synthetic benzophenone
analogues have been developed and are currently important lead molecules for future
antiviral therapies. These analogues are drug candidates for new non-nucleotide reverse
transcriptase inhibitors (NNRTIs) have been reported to display a broad spectrum of
antiviral activity against HIV-1 and drug resistant mutants.71 The benzophenone analogue
GW678248 (30) showed potent antiviral activity in vitro and thus was selected for further
preclinical studies.
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Several synthetic benzophenone analogues showed potent activity in vitro against
clinically relevant drug resistant mutants of HIV-1. Effective synthetic analogues were
obtained by comparing antiviral activity to the NNRTIs nevirapine and efavirens.
Several drug resistant strains were included in a HeLa-CD4 MAGI screening
assay. The nevirapine resistant strain Y181C was used to test the activity of 30. The
results showed an IC50 = 0.7  0.5 nM for 30 and an IC50 = 10,300  4,100 nM for
nevirapine.71 Another strain, K103N, was included in the panel. The analogue (30)
showed an IC50 = 1.0  0.9 nM while efavirens showed an IC50 = 25  13 nM, against this
particular strain.71
Structure-activity studies have shown that the lead structure of 30 binds to the
non-nucleoside binding site of the enzyme, thus forming an enzyme complex.72 The part
of the ring structure of 30 that reached the hydrophobic pocket was ring A, while the
modified C-ring of 30 counters the scaffold of the benzophenone structure, displaying
hydrophilic interactions. This synthetic analogue has a p-chloro substituent in the B-ring,
which is important for the activity in particular against the resistant mutants of the
virus.72 The additional C-ring is attached to the benzophenone core structure through a
linker region composed of an amide group and a secondary amine. It was found that the
carbonyl group in the benzophenone structure is important for activity.72 In addition, the
carbonyl group shows an intramolecular hydrogen interaction with the amide NH in the
linker region of this analogue (30).72 The para position of the C-ring was substituted with
a sulfonamide to increase activity.72 The hydrophobic A-ring of the benzophenone was
modified by adding a m-CN group, which showed the most potent activity of the tested
analogues.72 Lastly, the remaining meta position of the A-ring was substituted with a
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chlorine group72 to give this analogue a longer half-life and a lower clearance. This
analogue (30) was selected for further preclinical evaluation.
Pharmacokinetic studies were performed for this benzophenone analogue in rats,
dogs, and monkeys.72 The administration of an intravenous bolus dose of 1 mg/kg in 2 ml
injection (0.5 mg/ml) was followed by a clearance of 11, 7 and 10 ml/min/kg for rat, dog,
and monkey, respectively. The oral bioavailability was higher for a solution than a
suspension 27-58% for solution and 3-20% for a suspension, respectively.73 The prodrug
of this analogue (30) showed higher oral bioavailability and is currently undergoing
clinical studies. This drug candidate is currently in phase 2 of clinical trials and the future
drug is expected to provide benefit to HIV-1 infected patients with strains resistant to the
current NNRTIs.
2.6.3. Antiparasitic activities
Polyisoprenylated benzophenones showed potent activities as trypanocidal and
leishmanicidal agents (Table 2).74

75

Guttiferone A (5) was isolated from the leaves of

Garcinia intermedia (Pittier) Hammel and showed activity against Trypanosoma cruzi.
The flagellate protista T. cruzi is the etiologic agent of Chagas disease.74 The infectious
form is called trypanomastigotes is and the uninfectious form is designated epimastigotes.
Guttiferone A (5) showed higher activity against the trypomastigotes at MC100 = 50
g/ml, than against the epimastigotes at MC100 = 60 g/ml. These results represent the
concentration at which both the epimastigotes and trypomastigotes were terminated after
48h. Gossypol was used as a reference compound and showed trypanosomal activity at
MC100 = 50 g/ml. In vitro activity was found for 7-epiclusianone from Rheedia
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gardneriana Planch. & Triana against trypomastigotes of T. cruzi (LC50 = 260 g/ml),
although this was not confirmed in vivo.76
As for guttiferone A (5) and F (27), both displayed activities against Leishmannia
donovani, more potent than miltefosine, the reference compound in this study.
Leishmanicidal activity in vitro for guttiferone A (5) and F (27) were, IC50 = 0.2 and IC50
= 0.16 M, respectively. This was in comparison with miltefosine, IC50 = 0.47 M.
Given the strong leishmanicidal activity displayed by guttiferone A (5) and F (27) against
axenic amastigotes, these compounds are regarded as lead compounds in the synthesis of
novel potent and efficient leishmanicidal agents.
Isogarcinol (20) and cycloxanthochymol (21) were isolated from Moronobea
coccinea Aubl., and displayed antiplasmodial activity against Plasmodium falciparum,
particularly against a chloroquine resistant strain, FcB1. The antiplasmodial activity
reported for isogarcinol (20) and cycloxanthochymol (21) was IC50= 3.5 M and IC50=
2.1 M. Chloroquine showed an IC50= 0.078 M. The tetrahydropyrane ring present in
these compounds was reported to be responsible for activity against P. falciparum. In
addition it has been postulated that hydroxylation on the benzoyl moiety of the
benzophenone structure is important for the activity displayed by the tested compounds.77
Antiplasmodial activity for guttiferone A was IC50 = 3.17 M.78
2.7. Antioxidant activities
The antioxidant activity of garcinol (1) was investigated in four different systems,
using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay, superoxide anion scavenging
assay, hydroxyl radical scavenging assay, and the H2O2/NaOH/DMSO system.26, 41, 79 The
latter was particularly designed to evaluate both hydrophilic and hydrophobic free radical
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scavengers.26 It was shown that garcinol (1) has high antioxidant activity in comparison
with ascorbic acid and -tocopherol. In addition, garcinol (1) showed significant
chelating activity and it was noted that garcinol (1) showed high scavenging activity
against hydroxyl radicals in comparison with -tocopherol.26 This was further
investigated in vivo, and it was shown that garcinol (1) efficiently prevented the
development of gastric injury and ulcer, in comparison with a positive control26 These
findings are confirmed by ethnobotanical practice and traditional use of G. brasiliensis,
which has been reported in Brazilian folk medicine to treat peptic ulcer.80
Free radicals and reactive oxygen species (ROS) are involved during
carcinogenesis, neurodegenerative diseases, and inflammatory processes. The formation
of ROS in brain tissue and subsequent oxidative damage is involved in various
neurodegerenative diseases. Antioxidants are suggested to have neuroprotective effects.
The neuroprotective effect of garcinol (1) from G. indica was evaluated. It was found that
garcinol (1) protects against neuronal injury by reducing the generation of free radicals.
The production of ROS occurs through several intracellular pathways, which
involve mainly the activities of cyclooxygenase (COX), lipooxygenase, and inducible
nitric oxide synthase (iNOS). During oxidative stress, astrocytes in the central nervous
system (CNS) produce nitric oxide. It is specifically the iNOS in astrocytes that produces
nitric oxide, which leads to neuronal death in the CNS.24 It has been shown that garcinol
(1), reduced the expression of iNOS in a dose dependent manner and, subsequently, the
production of nitric oxide in astrocytes, and more importantly, the effects of garcinol (1)
enhanced neuronal survival.24 These findings suggest that polyphenols with antioxidant
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activity from medicinal plants protect against the formation of ROS preventing neuronal
cell death of neurons.
2.8. Antiinflammatory Activities
Results from several studies81, 82 have suggested that garcinol (1) possesses antiinflammatory and anti-carcinogenic activities. Changes in arachidonic acid (AA)
metabolism and increased production of nitric oxide (NO) play an important role in the
process of inflammation. Cytosolic phospholipase A2 (cPLA2), cyclooxigenases (COX),
lypooxigenases (LOX) and NO synthases are involved in the arachidonic acid synthesis
and NO production.81 Therefore, modulation of the arachidonic acid metabolism or NO
synthesis, by suppressing the enzymes that are involved in their production is an effective
way to suppress inflammation.
Hong et al.,81 found that garcinol (1) at 1 µM modulates arachidonic acid
metabolism in lipopolysaccharide (LPS)-stimulated murine macrophages, mainly
blocking the activation of cPLA2 by inhibition of protein ERK1/2 phosphorylation. In
addition, garcinol (1) suppressed iNOS expression and NO formation by modulation of
the JAK/SAT-1 signaling pathway. Moreover, the same study 81 showed that garcinol (1)
added to macrophages before the LPS treatment can interact with LPS receptors in these
cells and suppress COX-2 expression. Koeberle et al.82 has shown that garcinol (1) exerts
antiinflammatory and anticarcinogenic activities in vitro and in vivo by interacting with
5-lipoxygenase (5-LO) and microsomal prostaglandin E2 synthase-1 (mPGES-1), two
enzymes that are involved in inflammation and carcinogenesis. Human 5-LO and
mPGES-1 are also molecular targets for garcinol (1), which can be used as a template for
development and production of new drugs with antiinflammatory properties.
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Furthermore, Neves et al. showed that 7-epiclusianone (22) isolated from G.
brasiliensis fruit pericarp has anti-anaphylactic properties.80 In vitro experiments, using a
model of anaphylactic histamine release from ileum tissue, have shown that 7epiclusianone (22) exhibited mast cells stabilizing properties by inhibiting allergen
evoked histamine release in a dose-dependent manner with IC50 = 3.8 ± 1.8 nM. In
comparison, the standard anti-allergic compound azelastine used as a control showed
IC50= 6.6±2.8 nM. It was also found that 7-epiclusianone and azelastine inhibited
allergen induced guinea pig ileum contractions with IC50 = 2.3 ± 1.1 µM and IC50 = 3.3 ±
1.2 µM, respectively. Results from this study suggest that 7-epiclusianone (22) can be
used as a model for future drug development with anti-anaphylactic properties.
It was suggested that 7-epiclusianone (22) had putative mast cell stabilizing
properties; however the antihistamine effect ex-vivo of 7-epiclusianone (22) was not as
potent when compared to azelastine, a histamine H1 receptor antagonist. The inhibitory
concentration was IC50 = 3.7  0.1 M for 7-epiclusianone (22), and IC50 = 6.3  0.2 nM
for azelastine.80 Thus the pharmacological effect of 7-epiclusianone (22) when tested in
ex vivo guinea pig ileum experiments indicated that it inhibited acetylcholine induced
ileum contractions. It was suggested that 7-epiclusianone (22) exerts its effect by
blocking the influx of Ca2+.80
In a more recent study, benzophenone compounds isolated from Hypericum
thasium Griseb. namely; 3´,4,5´,6-tetrahydroxy-2-O--D-xylosylbenzophenone (31) and
3,´4,5´,6,-tetrahydroxy-2-O-(4-O-acetyl--D-xylosyl)benzophenone (32), suppressed the
oxidative burst of neutrophils; however quercetin and isoquercetin showed higher activity
in this study than the tested benzophenones.83
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2.9. Toxicology
Although no toxicological studies on natural isopolyisoprenylated benzophenones
have been reported, synthetic benzophenones on the other hand are widely used as UVscreens and cosmetics and have been the subject of a number of toxicological studies.
UV-screens are topically used and thus may be transcutaneously absorbed.
Benzophenone-2 (33) binds to both the estrogenic receptors, ER and ER. In addition,
(33) had powerful estrogenic effects, showing estrogenic effects on uterine tissues.84
The highest concentration of (33) and its conjugates, BP2-sulfate and BP2glucuronide, was observed in urine after 120 minutes of administration (298 g/ml, 1973
g/ml and 822 g/ml).85 For orally administered 33 it has been shown that the first-pass
metabolism of the drug is likely to take place in the gastrointestinal lumen, and not in the
liver, and this would possibly explain the rapid elimination from plasma.85 The
administration of an intravenous bolus dose of 100 mg/kg of benzophenone (34) to rats
was followed by the detection of peak plasma concentration after 4 hours. The peak
plasma concentration was Cmax = 2.06  0.46 g/ml, after which the concentration of (34)
slowly declined. The elimination half-life was t1/2= 19 hours and the area under curve
(AUC) was 47.17  5.52 g/ml h. Hence, apparent clearance was 2.20  0.22 ml/h/kg.86
This kinetic study and metabolic profile of (34) in rats was performed using gas
chromatography and mass spectrometry.86 Only the free, unconjugated forms of the
metabolites were detected by this method. These included the parent compound, 4hydroxybenzophenone and benzohydrol. Even though conjugated benzophenones
metabolites could not be detected by the reported method, the kinetic behavior of 34
suggested that it is rapidly absorbed through the gastrointestinal tract. The high
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absorption rate is mainly due to the degree of lipophilicity of the two aromatic rings. The
compound (34) rapidly disappears from plasma and the main route of elimination appears
to be urine; however, rapid elimination from plasma might be due to redistribution to
other compartment of the body or binding to plasma proteins.86
Kinetic studies suggest that the synthetic benzophenones are metabolized to
glucuronide- and sulfate-conjugates before being eliminated. These findings are
confirmed for garcinol (1) since its oral administration in rats showed an increased
activity of phase II enzymes, particularly glutathione S-transferase and quinone
reductase.81 Studies in rat hepatocytes, however suggests that benzophenone compounds
from Hypericum annulatum Moris are metabolized by the cytochrome P450 enzyme
CYP2A6.87 Oral administration of 10 mg of garcinol (1) was studied in CD-1 female
mice.81 The peak plasma level was 12 M and urine level was 2.7 M, suggesting that
the polyisoprenylated benzophenones are likely to be eliminated through urine.81
Further toxicological studies and pharmacokinetic studies remain to be conducted
for garcinol to establish the toxicological and kinetic profile of these compounds and
metabolites formed during elimination.
2.10. Conclusions and future prospects
Polyisoprenylated benzophenones isolated from the genus Garcinia in the
Clusiaceae family have been widely studied. These secondary metabolites have diverse
pharmacological properties including antiinflammatory, antimicrobial, and cytotoxic
effects. Evidence presented in this review suggests that polyisoprenylated benzophenones
induce apoptosis and arrest the cell cycle early in G1–phase. These compounds prevent
the transcription and translation of important cell cycle regulators such as cyclins, which
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are involved in cell progression. Thus they arrest the cell cycle and interrupt cell division
and inhibit the growth of cancer cells. The mechanism of action involves the inhibition of
mediators in the Akt/mTOR stress pathway. Although the specific target still remains
unknown, natural benzophenones might reveal new targets for future therapies.
Benzophenone compounds have low toxicity and can be synthetically modified to
produce new active molecules for future anticancer drugs and treatments for other
diseases.

Table 2.1. Cytotoxic activities of benzophenone compounds isolated from natural sources
Compounds
Source
Cell Line
Results
SW-480
colon
cancer
cell
line
IC
=33.3
(24-33) µM
50
Garcinia
Aristophenone A
xanthochymus
CC50 = 0.17 mM
Cudraphenone A
Cudraphenone B
Cudraphenone C

HSC-2 oral squamous
carcinoma cell line
HGF normal human gingival
fibroblasts

CC50 = 0.43 mM
CC50 = 0.036 mM
CC50 = 0.090 mM
CC50 = 0.092 mM
CC50 = 0.19 mM
CC50 = 0.052mM
CC50 = 0.19 mM

Raji cells

IC50 = 10.2 ±1.4 µM

IC50 =11.4 µM
IC50 =12.0 µM

Garcinia indica

Colon cancer cell lines:
HT-29
HCT-116
Normal immortalized intestinal
cells:
IEC-6
INT-407
HL-60 leukemia cell line

IC50 = 9.42 µM

Garcinia indica

HL-60 leukemia cell line

EC50 > 10 µM

Cudrania
cochinchinensis

Cudraphenone D
Garcinia assigu

Garcinia indica
Garcinol

Garcinia purpurea
Guttiferone A
Guttiferone E

Garcinia
macrophylla
Garcinia pyrifera

IC50 =21.4 µM
IC50 =19.4 µM

Comments
Aristophenone A exhibited cytotoxicity against SW-480 colon cancer
cells by inducing apoptosis. [25]
Cudrophenones A-D exhibited stronger cytotoxic activity against
HSC-2 human oral squamous carcinoma cells compared to HGF
normal human gingival fibroblasts. [45]
Positive control : 6-prenyl-4',5,7-trihydroxy-isoflavone
CC50 = 0.12 mM (HSC-2)
CC50 = 0.25 mM (HGF)

Cancer chemo-preventive effects could be associated with the free
radical scavenging properties of garcinol. [52]
Positive control: Vitamin E IC50 =22.8±02 µM
Garcinol exhibited cytotoxicity against colon cancer cells by inducing
apoptosis, mainly increasing caspase-3 activity. Low concentrations
<1 µM stimulated the growth of cancer and normal cells ranging from
10 to 100%. [42]

Garcinol exhibited cytotoxicity against human leukemia cells by
affecting caspase-3 and caspase-2 activity. Garcinol-induced apoptosis
was related to the release of mitochondrial cytochrome C and loss of
mitochondrial intermembrane potential. [43]
Garcinol exhibited cytotoxicity against human leukemia cells by
inducing apoptosis. It caused inhibition of NO generation and H2O2
production. [53]
Garcinol exhibited cytotoxicity against leukemia cells by activation of
caspase 3 and decrease in mitochondrial transmembrane potential,
subsequently leading to apoptosis. [37]

Leukemia cell lines:
NB4
K562
U937
HL60
A2780 ovarian cancer cell line

IC50 = 6.8 µg/ml

Guttiferone A exhibited cytotoxicity against human ovarian cancer
cells. Positive control: Actinomycin D IC50 = 0.003 µg/ml. [33]

KB- oral carcinoma cell line

IC50 =10 µM a

Mixture of guttiferone E and xanthochymol exhibited cytotoxicity
against KB cell lines. Guttiferone E was associated with inhibition of
the disassembly of microtubules into tubulin with IC50 =1.5 µM.
Positive control: Paclitaxel IC50 =0.006 µM. [34]

Garcinol was shown to be
cytotoxic at a dose ranging
from 5 to 20 µM
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Guttiferone E

Guttiferone G

Guttiferone H

Garcinia
xanthochymus

Garcinia
macrophylla

Garcinia
xanthochymus

Human colon cancer cell lines :
HCT 116
HT 29
SW-480
SW-480 colon cancer cell line

A2780 ovarian cancer cell line

Guttiferone J

IC50 = 8.0 µg/ml

Guttiferone E caused growth inhibition of colon cancer cells by
activation of endoplasmic reticulum stress response, subsequently
affecting the cell cycle. [37]
Guttiferone E exhibited cytotoxicity against SW-480 colon cancer
cells by inducing apoptosis. [25]

Guttiferone G exhibited cytotoxicity against human ovarian cancer
cells. [33]
Positive control: Actinomycin D. IC50 = 0.003 µg/ml.
Guttiferone E caused growth inhibition of colon cancer cells by
activation of endoplasmic reticulum stress response, subsequently
affecting the cell cycle. [38]

Human colon cancer cell lines :
HCT 116
HT 29
SW 480

IC50 =9 (8-12) µM
IC50 =13 (10-17) µM
IC50 =16 (12-20) µM

SW-480 colon cancer cell line

IC50 =12.4 (10.5-12.0) µM

Guttiferone H exhibited cytotoxicity against SW-480 colon cancer
cells by inducing apoptosis. [25]

IC50 = 4.70 µg/ml

Both guttiferone I and guttiferone J exhibited cytotoxicity against KB
cell lines which was not associated with inhibition of tubulin
polymerization in the cell. [47]
Positive control: Taxotere IC50 = 0.37 ng/ml

Guttiferone I
Garcinia virgata

IC50 =9 (8-12) µM
IC50 =14 (10-19) µM
IC50 =17 (14-21) µM
IC50 =7.5(6.1-7.8) µM

KB- oral carcinoma cell line

IC50 = 5.0 µg/ml

Garcinia
yunnanensis

HeLa-C3 cervical cancer cell
line

Guttiferone K was shown
to be cytotoxic at a dose of
20 µg/ml

It was shown that guttiferone K at a concentration of 20 µg/ml can
initiate apoptosis in HeLa-C3 cervical cancer cells. Concentration of
10 µg/ml was not active. [49]

Rheedia calcicola

A2780 ovarian cancer cell line

IC50 = 3.6 µg/ml

Guttiferone K exhibited cytotoxicity against A2780 human ovarian
cancer cells. [32]

Rheedia calcicola

A2780 ovarian cancer cell line

IC50 = 3 µg/ml

Guttiferone L exhibited cytotoxicity against A2780 human ovarian
cancer cells. [32]

A549- lung cancer cell line
MCF-7 -breast cancer cell line

IC50 =13.7 mcg/ml
IC50 =10.0 mcg/ml

Both hyperibone K and hyperibone L exhibited cytotoxicity against
lung and breast cancer cells. [30]

Hyperibone L

Hypericum
scabrum

Isogarcinol

Garcinia assigu

Raji cells

Guttiferone K

Guttiferone L
Hyperibone K

IC50 =9.2 mcg/ml
IC50 =15.0 mcg/ml
IC50 = 13.3 ±1.3 µM

Cancer chemo-preventive effects could be associated with the free
radical scavenging properties of isogarcinol. [52]
Positive control : Vitamin E IC50 =22.8±02 µM
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Isogarcinol
Garcinia purpurea

Garcinia indica
Isoxanthochymol

Garcinia pyrifera

Clusia rosea
Nemorosone

Cuban propolis
Clusia sp.
Ochrocarpinone A
Ochrocarpinone B
Ochrocarpinone C
Tovophenone A
Tovophenone B
Tovophenone C
Vismiaguianone A
Vismiaguianone B
Vismiaguianone C

Ochrocarpos
punctatus

Leukemia cell lines:
NB4
K562
U937
HL60

Isogarcinol was shown to
be cytotoxic at a dose
ranging from 5 to 20 µM

MCF-7 breast cancer cell line
WRL-68 liver cancer cell line
COLO-320-DM colon cancer
cell line

IC50 =2.85 µM
IC50 =15.52 µM
IC50 =4.85 µM

KB- oral carcinoma cell line

IC50 =5.8 µMb

Leukemia cell lines:
HL60 WT
HL60 ADR MDR1+
CEM WT
CEM VBL MDR1+
Jurkat WT
Tanoue WT
Kasumi WT
K-562 WT
HeLa-cell line
Hep-2 cell line
PC-3 cell line
U251- cell line

IC50 = 2.66±0.66 µM
IC50 = 2.56±0.05 µM
IC50 = 3.10±0.11 µM
IC50 = 3.00±0.06 µM
IC50 = 2.30±0.08 µM
IC50 = 2.10±0.05 µM
IC50 = 2.60±0.25 µM
IC50 = 2.10±0.06 µM
IC50 = 1.6±0.08 µg/ml
IC50 = 1.5±0.08 µg/ml
IC50 = 3.6±0.65 µg/ml
IC50 = 1.9±0.70 µg/ml

A2780 ovarian cancer cell line

IC50 = 6.9 ±0.3µg/ml
IC50 = 7.4 ±0.2µg/ml

Isogarcinol exhibited cytotoxicity against leukemia cells by activation
of caspase 3 and decrease in mitochondrial transmembrane potential,
subsequently leading to apoptosis. [37]

Isoxanthochymol exhibited growth inhibition in MCF-7, WRL-68 and
COLO-320 cancer cell lines. The same study suggested that
isoxanthochymol/ xanthochymol mixture (2:1) is more cytotoxic than
isoxanthochymol alone. [20]
Positive control: Paclitaxel
IC50 =0.005 µM (MCF-7)
IC50 =0.054 µM (WRL-68)
IC50 =0.01 µM(COLO-320)
Mixture of isoxanthochymol and cycloxanthochymol exhibited
cytotoxicity against KB cancer cells. [34]
Positive control:Paclitaxel IC50 =0.006 µM
Nemorosone exhibited cytotoxicity against different lines of leukemia
cells mainly by downregulation of the protein levels of cyclins
involved in the cell cycle control. These effects are mainly attributed
to the negative modification of the Akt/PKB pathway. [36]

Nemorosone exhibited strong cytotoxicity against cervix carcinoma,
larynx cancer, prostate cancer, and nervous system cancer cell lines.

[65]

Ochrocarpinones A-C exhibited cytotoxicity against A2780 ovarian
cancer cells. [31]

IC50 = 8.2 ±0.3µg/ml

Tovomita
brevistaminea

KB- oral carcinoma cell line

EC50 =10.0 µg/ml-1
EC50 =9.0 µg/ml-1

The authors considered tovophenones A-C inactive against KB cancer
cells because EC50 values were bigger than 5 µg/ml-1. [50]

EC50 =8.2 µg/ml-1
EC50 > 20 µg/ml-1
EC50 > 20 µg/ml-1

Vismia guianensis

Vismiaguianones D-E exhibited moderate cytotoxic activity against
KB oral cancer cells, while vismiaguianones A-C were inactive. [35]

EC50 > 20 µg/ml-1
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KB- oral carcinoma cell line

Vismiaguianone D
Vismiaguianone E

EC50 = 3.3±1.5µg/ml-1

Garcinia indica

Xanthochymol

a

EC50 = 2.4±0.9µg/ml-1

MCF-7 breast cancer cell line
WRL-68 liver cancer cell line
COLO-320-DM colon cancer
cell line

IC50 =0.475 µM
IC50 =2.52 µM
IC50 =0.62 µM

Garcinia pyrifera

Leukemia cell lines:
NB4
K562
U937
HL60
KB- oral carcinoma cell line

IC50 =10 µM a

Garcinia
xanthochymus

Human colon cancer cell lines :
HCT 116
HT 29
SW 480

IC50 =10 (7-13) µM
IC50 =15 (11-19) µM
IC50 =17(14-21) µM

SW 480- colon cancer cell line

IC50 =8.3(7.0-8.2) µM

Garcinia purpurea

Xanthochymol was shown
to be cytotoxic at a dose
ranging from 5 to 20 µM

Vismiaguianones D-E exhibited moderate cytotoxic activity against
KB oral cancer cells, while vismiaguianones A-C were inactive. [35]
Xanthochymol exhibited growth inhibition in MCF-7, WRL-68 and
COLO-320 cancer cell lines. The same study suggested that
isoxanthochymol/ xanthochymol mixture (2:1) is more cytotoxic than
xanthochymol alone. [20]
Positive control: Paclitaxel
IC50 =0.005 µM (MCF-7)
IC50 =0.054 µM (WRL-68)
IC50 =0.01 µM(COLO-320)
Xanthochymol exhibited cytotoxicity against leukemia cells by
activation of caspase 3, subsequently leading to apoptosis. [37]

Mixture of xanthochymol and guttiferone E exhibited cytotoxicity
against KB cancer cells. Xanthochymol was associated with inhibition
of the disassembly of microtubules into tubulin with IC50 =2 µM. [34]
Positive control: Paclitaxel IC50 =0.006 µM
Xanthochymol caused growth inhibition of colon cancer cells by
activation of endoplasmic reticulum stress response, subsequently
affecting the cell cycle. [37]
Xanthochymol exhibited cytotoxicity against SW 480- colon cancer
cells by inducing apoptosis. [25]

(Mixture xanthochymol /guttiferone E), b (Mixture of isoxanthochymol/cycloxanthochymol)
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Table 2.2. Antibacterial, antiviral, and antiparasitic activities of benzophenone compounds isolated from natural sources
Compounds
Source
Strain
Results
Comments and Reference
LC50 =260 µg/ml
7-Epiclusianone exhibited tripanocidal activity in vitro. It
Rheedia gardneriana
Trypanosoma cruzi
was inactive tested in vivo in mice. [76]
Rheedia brasiliensis

Streptococcus mutans

MIC= 1.25-2.5 µg/ml
MBC=10-20 µg/ml

Hypericum sampsonii

Staphylococcus aureus

MIC= 4 µg/ml (7.3 µM)

7-Epiclusianone

IC50 = 10.1 ± 4.6 µM

7-Epi-garcinol
Moronobea coccinea

Chamone I
Coccinone A
Coccinone B
Coccinone C
Coccinone D
Coccinone E
Coccinone F
Coccinone G
Coccinone H
Cycloxanthochymol

Garcinol
(Camboginol)

[77]

Plasmodium falciparum
IC50 = 5.1 ± 1.3 µM

7-Epi-isogarcinol

Clusia grandiflora

Moronobea coccinea

Paenibacillus larvae
Paenibacillus alvei

Plasmodium falciparum

Allanblackia monticola

Leishmania donovani

Garcinia bancana

(MRSA)-Methicillin-resistant

Garcinia purpurea

(MRSA)-Methicillin-resistant

19.7±0.3mm a (35h)
10±0.6mm a (35h)

Control: Chloroquine IC50 = 0.078 ± 0.006 7µM
7-epi-isogarcinol exhibited strong antiplasmodial activity
against chloroquine-resistant strain of P. falciparum FcB1
strain. [77]
Chamone I exhibited strong antibacterial activity against
honeybee pathogens. [63]

IC50 = 4.3 ± 0.5 µM
IC50 = 5.5 ± 0.4µM
IC50 = 9.0 ± 1.2 µM
IC50 = 7.0 ± 0.9µM
IC50 = 4.9 ± 0.7µM
IC50 = 17.0 ± 9.4 µM
IC50 = 19.2 ± 5.9µM
IC50 = 16.6 ± 6.1µM
IC50 = 2.1 ± 0.5 µM

Coccinones A-E along with cycloxanthochymol exhibited
strong antiplasmodial activity, while coccinones F-H
exhibited moderate activity against chloroquine-resistant
strain of P. falciparum FcB1. [77]
Control: Chloroquine IC50 = 0.078 ± 0.006 7µM

IC50 =0.82 µM

Garcinol exhibited leishmanicidal activity in vitro. [75]
Standard: Miltefosine- IC50 =0.47 µM

IC50 =0.33 µM

Camboginol exhibited leishmanicidal activity. [75]
Standard: Miltefosine- IC50 =0.47 µM
Garcinol exhibited antibacterial activity against methicilinresistant S.aureus. [60]
Garcinol exhibited strong antibacterial activity against
MRSA. [59]Control: Vancomycin MIC= 6.25 µg/ml

MIC=16 µg/ml

Staphylococcus aureus
Staphylococcus aureus

Control: Gentian violet LC50 =7.5 µg/ml
7-Epiclusianone exhibited antibacterial activity. [61]
Positive control: Chlorhexidine MIC= 1-2 µg/ml
MBC=8 µg/ml
7-Epiclusianone exhibited antibacterial activity against S.
aureus SA-1199B strain. [22]
Positive control: Norfloxacin MIC= 32µg/ml (100 µM)
7-epi-garcinol exhibited moderate antiplasmodial activity
against chloroquine-resistant strain of P. falciparum FcB1.

MIC= 6.25-12.5 µg/ml
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Garciosaphenone A

Guttiferone A

Guttiferone F

Guttiferone I

Isogarcinol

Moronobea coccinea

Plasmodium falciparum

IC50 = 12.6 ± 4.8 µM

Garcinia speciosa

HIV-1

IC50 =23.9 µg/ml

Garcinia intermedia

Trypanosoma cruzi

MC100=100 µM (Epimastigotes)
MC100=83µM (Trypomastigotes)

Guttiferone A exhibited trypanocidal activity.

Symphonia globulifera

Leishmania donovani

IC50 =0.16 µM

Guttiferone A exhibited strong leishmanicidal activity.

Symphonia globulifera

Plasmodium falciparum

IC50 = 3.17 µM

Allanblackia monticola

Leishmania donovani

IC50 =0.20 µM

Allanblackia
stuhlmannii

HIV-1

EC50 =23µg/ml

Citrobacter freundii
Enterobacter cloaclae
Proteus vulgaris
Bacillus megaterium
Streptococcus faecalis

MIC= 1.22 µg/ml

Garcinia purpurea

(MRSA)-Methicillin-resistant

MIC= 12.5 µg/ml (MRSA)

Moronobea coccinea

Plasmodium falciparum

IC50 = 3.5 ± 1.1 µM

Garcinia smeathmannii

Bacillus cereus
Bacillus stearothermophylus

MIC= 9.76 µg/ml

(MRSA)-Methicillin-resistant

MIC >25 µg/ml*

Garcinia smeathmannii

[69]

Microsphaerin A
Microsphaerin B
Microsphaerin C

[74]

[75]
Standard: Miltefosine- IC50 =0.47 µM
Guttiferone A exhibited antiplasmodial activity. [78]
Guttiferone F exhibited strong leishmanicidal activity.[75]
Standard: Miltefosine- IC50 =0.47 µM
Gutifferone F exhibited HIV-1 inhibitory activity in vitro.

[22]
MIC= 1.22 µg/ml
MIC =1.22 µg/ml
MIC =0.61 µg/ml
MIC =0.61 µg/ml

Staphylococcus aureus

MIC= 4.88 µg/ml

Staphylococcus aureus
(MRSA)-Methicillin-resistant

Staphylococcus aureus

Guttiferone I exhibited antibacterial activities against both
gram-positive and gram-negative bacteria. [21]
Control: Gentamycin
MIC= 4.88 µg/ml
MIC= 4.88 µg/ml
MIC= 1.22 µg/ml
MIC= 2.44 µg/ml
MIC= 2.44 µg/ml
Isogarcinol exhibited antibacterial activity against MRSA.

[59]

Isoxanthochymol
Garcinia subelliptica

Garcinol exhibited moderate antiplasmodial activity against
chloroquine-resistant P. falciparum FcB1 strain. [77]
Control: Chloroquine IC50 = 0.078 ± 0.006 7µM
Garciosaphenone A exhibited HIV-1 inhibitory activities.

IC90 =3.0 µM
IC90 =3.0 µM
IC90 =5.0 µM

Control: Vancomycin MIC= 6.25 µg/ml
Isogarcinol exhibited strong antiplasmodial activity against
chloroquine-resistant strain of P. falciparum FcB1. [77]
Control: Chloroquine IC50 = 0.078 ± 0.006 7µM
Isoxanthochymol exhibited antibacterial activities against
gram-positive bacteria. [21]
Control: Gentamycin
MIC= 1.22 µg/ml
MIC= 4.88 µg/ml
Mixture of isoxanthochymol/cycloxanthochymol exhibited
weak antibacterial activity. [59]
Control: Vancomycin MIC= 6.25 µg/ml
Microsphaerins A-C exhibited strong antibacterial activity
against MRSA. [67]
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Microsphaeropsis sp. b
Microsphaerin D

(F2076) and (2078)

Nemorosone II

Clusia grandiflora

Pestalachloride A
Pestalachloride B

Pestalotiopsis adustac

Pestalachloride C

Staphylococcus aureus
MRSA
Enterococcus faecalis
Streptococcus pneumonia
Bacillus subtilis
Escherichia coli
Klebsiella pneumoniae
Moroxella catarrhalis
Haemophilus influenzae
Pseudomonas aurogenosa
Paenibacillus larvae
Paenibacillus alvei
Fusarium culmorum
Gibberrella zeae
Verticillium aibo-atrum
Fusarium culmorum
Gibberrella zeae
Verticillium aibo-atrum
Fusarium culmorum
Gibberrella zeae
Verticillium aibo-atrum

IC90 =1.3 µM
IC90 =1.0 µM
IC90 =1.3 µM
IC90 =3.6 µM
IC90 =3.0 µM
IC90 >50 µM
IC90 >50 µM
IC90 =1.3 µM
IC90 >50 µM
IC90 >50 µM

Microsphaerin D exhibited strong antibacterial activity
against gram-positive bacteria; but it was not active against
gram-negative bacteria with one exception (K.
pneumoniae). [67]

19.5±1.6 mm a (35h)
2.3 ± 2.3 mm a (35h)

Nemorosone II exhibited strong antibacterial activity
against honeybee pathogens. [63]

IC50 =0.89±0.10µM / MIC=7.2 µM
IC50 =54.4±0.8µM / MIC=114.4µM
IC50 =58.3±1.4µM / MIC=114.4µM

Pestalachlorides A-B exhibited strong antifungal activities
against plant pathogens. Pestalachloride C did not exhibit
significant activity against the same plant pathogens. [43]

IC50 =4.7±0.2µM / MIC=49µM
IC50 =1.1±0.08µM / MIC=12.2µM
IC50 =7.9±0.2µM / MIC=12.2µM
IC50 > 118.5µM / MIC >236.9µM
IC50 > 118.5µM / MIC >236.9µM
IC50 > 118.5µM / MIC >236.9µM

(MRSA)-Methicillin-resistant

Staphylococcus aureus
Pestalone

Vismiaphenone D
Vismiaphenone E
Vismiaphenone F
Vismiaphenone G
Xanthochymol
a

Pestalotia sp.d

Vancomycin –resistant
Enterococcus faecium

MIC= 78 ng/ml

HIV

EC50 =11 µg/ml
Inactive
Inactive
Inactive

Only vismiaphenone D exhibited HIV inhibitory activity,
while vismiaphenones E-G were inactive. [70]

(MRSA)-Methicillin-resistant

MIC= 3.13-12.5 µg/ml (MRSA)

Xanthochymol exhibited strong antibacterial activity
against MRSA. [59]
Control: Vancomycin MIC= 6.25 µg/ml

Vismia cayennensis

Garcinia subelliptica

MIC= 37 ng/ml

Pestalone exhibited strong antibacterial activity against two
lines of antibiotic resistant bacteria. [66]

Staphylococcus aureus

Total inhibition, bAnamorphic fungus , c Plant endophytic fungus, d Marine fungus, * Mixture of isoxanthochymol/cycloxanthochymol
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Figure 2.1. General structure of polyisoprenylated benzophenone
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Figure 2.2. Polyisoprenylated benzophenones from natural sources and synthetic analogues
(compounds 1-34)
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Figure 2.2. (Continued) Polyisoprenylated benzophenones from natural sources and synthetic
analogues (compounds 1-34)
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Figure 2.2. (Continued) Polyisoprenylated benzophenones from natural sources and synthetic
analogues (compounds 1-34)

44

Figure 2.2. (Continued) Polyisoprenylated benzophenones from natural sources and synthetic
analogues (compounds 1-34)
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Chapter 3
Benzophenones and Biflavonoids Antioxidants from Garcinia intermedia fruits
(Clusiaceae)

FRUI
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3.1. Introduction
As part of our ongoing studies of antioxidants from tropical edible fruits,
we have studied Garcinia intermedia (Pittier) Hammel.88 Garcinia intermedia is a 30 m
high tree with yellow latex, native to the Central American lowland tropical rain-forest.
The leaves are opposite, leathery, dark-green on the adaxial surface, brownish on the
abaxial surface, 8-15 cm long and 2-5 cm wide, although the leaf-shape can be elliptic,
lanceolate or oblong. The flowers are white, joined in clusters and have four petals. The
male flowers have 25-30 stamens. The fruits are yellow and are oval or oblong, 2-3 cm
long, with a smooth thin skin. The seeds are 1-2. The fruit is sweet and matures from late
January to March. It is the only Central American member of this genus with edible
exocarp. The wood has numerous gum ducts and it is immune to insects and it is
sometimes grown as an ornamental tree.89 Garcinia intermedia has many different
common names. It is called “waiki-plum” in Belize, “arrayán” and “palo de frutilla” in
Guatemala, “chaparrón” in El Salvador, “caimito” in Honduras, “jorco” in Costa Rica
and “sastra” in Panama. It is cultivated locally in Brazil and in the Philippines where it is
called “limão do matto” or “berba”, respectively.89
Guttiferone A, 8-desoxygartanin, podoscarpusflavone A, amentoflavone,
and friedelin have previously been identified in the leaves of this species.74 To our
knowledge no previous study has been done on the fruits of this species. Previous studies
have found that prenylated benzophenones have antiviral23 and insecticidal activities.90
We have found that prenylated benzophenone compounds from Garcinia xanthochymus
fruits have antioxidant and weak cytotoxic effect against colon cancer cells, SW480.25
Gene expression studies of cancer cells suggested that prenylated benzophenone
compounds interfere with the mitochondrial membrane potential and subsequently
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activates the endoplasmatic stress and cellular energy stress response pathways.
Guttiferone compounds induce cell-cycle arrest in G1-phase and induce apoptosis,38
suggesting that these compounds exert chemopreventive effects against cancer by
arresting their cell cycle of cancer cells.
It has been suggested that benzophenone compounds inhibit the
disassembly of microtubules, thus inhibiting cell replication through yet another
mechanism.34 Nevertheless, the specific cellular target of benzophenones exerting
cytotoxicity has not been described until now. Thus we tested the compounds isolated
from G. intermedia for inhibitory activity of the following cell cycle regulators;
DYRK1A, CK1, CDK5, and GSK3.
3.2. Results and discussion
In our study of antioxidants from the fruits of G. intermedia we have
identified six benzophenones; guttiferone A (1), guttiferone E (2), isoxanthochymol (3),
xanthochymol (4), aristophenone (5) maclurin (6), and two biflavonoids, volkensiflavone
(7) and fukugetin (8). Identification was made through comparison to previously isolated
standards and based on literature data (Fig. 3.1). Compound 9 was analyzed by
HRESIMS and by 1D and 2D NMR experiments, which led to the identification and
characterization of its structure (Fig. 3.2). The compound showed the UV absorption at
max 233 and 279 nm, which is distinctive of benzophenone compounds. The HRESIMS
spectrum showed a protonated molecule [M+H]+ of m/z 619.3568, which corresponded to
a molecular formula C38H50O7 calculated for 618.3557 and containing 14 degrees of
unsaturations.
The 1H-spectrum of 9 (Fig 3.3) showed an aromatic AMX splitting system
with resonances at  7.19 ppm d (J = 1.8 Hz), 7.06 ppm dd (J = 8.2, 1.8 Hz), and 6.72
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ppm d (J = 8.2 Hz). Three olefinic protons were detected at  5.03 ppm, 4.95 ppm and
4.90 ppm, indicating the presence of three isoprenylated substituting groups. The broad
proton signals at  4.90 and 4.76 ppm suggested the presence of a terminal methylene.
The 13C-NMR spectrum (Fig. 3.4) of compound 9 showed three signals at  192.0, 193.0
and 213.0 ppm, indicating the presence of three carbonyl groups. The resonance signals
of substituted aromatic carbons were detected at  133.5, 145.7 and 150.0 ppm. The
carbon signal at  75.6 ppm was assigned as C-34 and it corresponded to a methine signal
in the DEPT experiment (Fig. 3.5). The HSQC experiment (Fig. 3.6) confirmed that the
carbon at  75.6 ppm (C-34) was coupled to a proton at  3.94 ppm (d, J= 5.31).
Moreover, the HMBC experiment (Fig. 3.7) showed that the proton signal at  4.90 brs
ppm (H-32) correlates with carbon at  18.0 ppm (C-33), and to carbon at  75.6 ppm (C34). Furthermore, the proton at  1.67 ppm (H-33) showed strong correlations to carbons
at  17.6 ppm (C-33), 75.6 ppm (C-34), 110.2 ppm (C-32) and 148.5 ppm (C-31). In the
HMBC experiment, the proton at  4.76 brs ppm (H-32a), which appears as broad singlet
in the proton spectrum, correlated to carbon at  17.6 ppm (C-33) as well as to carbon at
 75.6 ppm (C-34). The COSY spectrum showed a correlation between proton at  3.94
(H-34) ppm and proton at  4.90 brs (H-32b) ppm. There are five methylene signals in
the 13C DEPT 135 spectrum.
The aromatic proton at  7.19 ppm (H-12) showed HMBC correlations to
carbons at  123.9 ppm (C-16), 145.7 ppm (C-13), 150.0 ppm (C-14), and 199.0 ppm (C10), this last correlation links the aromatic 3,4-dihydroxybenzoyl moiety to one of the
carbonyl carbons (C-10). Similarly, the aromatic proton at 7.06 ppm (H-16) showed
HMBC long-range correlations to carbons at  116.9 ppm (C-12), 150.0 ppm (C-14), and
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199.0 ppm (C-10). Proton at  6.72 ppm (H-15) correlates to carbons at  133.5 ppm (C11), 145.7 ppm (C-13), and 150 ppm (C-14). Moreover, proton at  2.80 ppm (H-30)
correlates to carbons at  39.4 ppm (C-29). Proton at  2.60 ppm (H-17) correlates to
carbon at  68.7 ppm (C-4), 132.7 ppm (C-19), 193.0 ppm (C-3), and 213.0 ppm (C-9). In
the bicyclo[3.3.1]nonane structure proposed, the proton at  2.00 (H- 7b) ppm correlates
to carbons at  39.4 ppm (C-29), 61.7 ppm (C-8), 192.0 ppm (C-1), and 213.0 ppm (C-9).
In addition, strong HMBC cross-peaks were identified from the methyl
group at  1.22 ppm s (H-22) correlating to carbon at  40.6 ppm (C-6) and 50.2 ppm (C5). Proton at  1.61 ppm was assigned as H-27 showed correlations coupling to carbon at
 17.8 ppm (C-28), 125.9 ppm (C-25), and 132.6 ppm (C-26).
During isolation of benzophenones and biflavonoids, antioxidant activity
was measured using the DPPH assay, previous to isolation of phytochemical constituents.
The methanol extract displayed low antioxidant activity (IC50= 118.1  0.94 µg/ml) in the
DPPH assay. The chloroform and ethyl acetate partitions showed high activity, IC50=
23.4  1.28 µg/ml and IC50= 41.4  3.66 µg/ml respectively, while the n-butanol partition
only had a moderate activity (68.0  1.41 µg/ml). The antioxidant activity of guttiferone
A (IC50= 46 µM) is comparable to that of gallic acid (IC50= 35 µM). The antiproliferative
effect of guttiferone A against HT-29 colon cancer cells was IC50= 15.8 µM (tested by
Dr. Linda Saxe-Einbond).
Fukugetin, volkensiflavone, and guttiferone A were analyzed for cyclin
dependent kinase activity and cell cycle regulation by DYRK1A, CK1, CDK5, and
GSK3; however, the tested compound did not show any activity on these cell cycle
mediators.
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Experimental Section
3.3. General experimental procedures
1H, 13C,

DEPT, HSQC, and HMBC NMR spectra were measured using a

Bruker Avance 300 MHz spectrometer. Sephadex LH-20 (Pharmacia Fine Chemicals,
Piscataway, NJ) and reversed-phase C18 silica gel (J.T. Baker, Phillipsburg, NJ) was used
for gel-filtration and column chromatography. MeOH (J.T Baker, Phillipsburg, NJ) was
used for extraction and isolation. TLC plates RP18 F254 (Merck, Darmstadt, Germany)
were used to monitor separation and isolation. Preparative HPLC was carried out to
separate a mixture of guttiferone A and isoxanthochymol using a Waters 600 controller
with Waters 486 tunable absorbance detector and a Phenomenex Luna C18 column (250
x 21.2 mm, 10 µm) and Phenomenex Synergi Hydro-RP C18 column (250 x 4.6 mm, 5
µm). A Waters 2695 separation module and a 996 photodiode array detector with a
Phenomenex Luna C18 column (250 x 4.6 mm, 5 µm) (Torrance, CA) were used to
analyze the main constituents. Molecular weights were obtained using a ThermoFinnigan
electrospray LCQ mass spectrometer in the negative mode. Absorbance was measured
using a microplate reader (Molecular Devices Versamax).
3.3.1. Plant material
Fruits of Garcinia intermedia were obtained from the Broward County Rare
Fruit and Vegetable Council, Florida. The collected fruits were shipped overnight and
stored at -20 °C at the Phytochemistry Laboratory, Lehman College, City University of
New York, Bronx, NY. A voucher specimen is kept at The William and Lynda Steere
Herbarium at the New York Botanical Garden, Bronx, NY.
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3.3.2. 1,1-Diphenyl-2-picrylhydrazyl (DPPH) assay
The DPPH antioxidant assay was performed according to previously
described procedures.91 Samples were dissolved in DMSO and further diluted before
being transferred to a 96-well microtiter plate. Each well contained 150 µL ethanolic
solution of DPPH (400 mM) and 50 µL of sample solution. The microtiter plates were
incubated at 37°C for 30 min and their absorbance were measured at UVmax 515 nm using
a microplate reader (Molecular Devices Versamax). The obtained data were used to
determine the concentration of the sample required to scavenge 50% of the DPPH free
radicals (IC50). The percent inhibition was plotted against concentration and the IC50 was
obtained from the fitted linear curve. In the experiments, the negative controls, ethanol
and DMSO, showed no antioxidant activity. Ascorbic acid was used as a positive control
(IC50 = 15 µg/mL). The CHCl3 partition displayed highest antioxidant activity in the
DPPH assay (IC50 = 23.4  1.28 µg/mL) and was further analyzed. The antioxidant
activity of guttiferone A (IC50 = 46 µM) is comparable to that of gallic acid (IC50 = 35
µM).
3.3.3. Extraction and isolation
To obtain minor benzophenone constituents, the seeds of G. intermedia
(358 g) were extracted three times in 2000 mL MeOH at room temperature. The MeOH
extract was evaporated in vacuo, and it yielded a residue, which was suspended in water
and then sequentially partitioned with 300 x 3mL CHCl3, EtOAc, and BuOH. The EtOAc
partition (6.95 g) was chromatographed over an open column with silica gel reversedphase C18, using a gradient solvent system composed of ammonium acetate (10 mM) and
MeOH, starting at (50:50)(0:100). Thirteen fractions were obtained and analyzed.
Fractions D through F were combined (8.6 mg). This sample contained a binary mixture
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of benzophenone compounds and was analyzed by 1D and 2D NMR. Structure
elucidation and identification of compound 9 was achieved from these experiments.
Analytical HPLC was used for further purification and to obtain compound
9, using a Synergi Hydro-RP column with a solvent system composed of ammonium
acetate buffer (10 mM) and MeOH. A linear gradient system was used; starting from
(50:50)(35:65), over 5 minutes, then running from (35:65)(25:75), over 18 minutes.
Then, finally, the isocratic condition (5:95) was run for 5 minutes, before restoring initial
conditions (50:50) for 10 min. The flow rate was 1 mL/min. Separation was monitored at
max 280 nm. A sample of 1.5 mg containing compound 9 was obtained for further NMR
analysis to identify compound 9.
The separations and fractions were monitored and combined using RP18TLC, developed in a mixture composed of ammonium acetate buffer (10 mM): MeCN
(5:95). The constituents were detected by spraying the TLC plate with a reagent
composed of 10% H2SO4 and 1% vanillin in EtOH and followed by heating. Analysis
during separations was performed using reversed-phase HPLC, with a solvent system
composed of ammonium acetate buffer (10 mM) and MeCN; a linear gradient of the
mixture (95:50:1) was run over 45 minutes at a flow rate of 1 mL/minute, holding
100% MeCN for 10 minutes. In addition, fractions were monitored by LC-MS.

1

H, 13C,

DEPT, HSQC and HMBC experiments were recorded in acetone-d6.
Guttiferone A (1): The UV (MeOH) absorption was max 233 and 279 nm; 1H-NMR (300
MHz, acetone-d6) The molecular weight obtained by negative electrospray ionization
mass spectrometry was m/z 601. The structure was identified by NMR and in compared
to data in previously published literature.68
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Guttiferone E (2): The UV (MeOH) absorption was max 241 and 279 nm. It was
identified by HPLC spiking experiment using available standards.
Isoxanthochymol (3): The UV (MeOH) absorption was max 233 and 279 nm. The
molecular weight obtained by negative electrospray ionization mass spectrometry was
m/z 601. The structure was identified by NMR and by comparison to previously
published literature data.68
Xanthochymol (4): The UV (MeOH) absorption was max 241 and 279 nm. It was
identified by HPLC spiking experiment using available standards.
Aristophenone (5): The UV (MeOH) absorption was max 243 and 310 nm. The
molecular weight obtained, by negative electrospray ionization spectroscopy, was m/z
534.
Maclurin (6): The UV (MeOH) absorption was max 228, 279 and 360 nm. The molecular
weight obtained, by negative electrospray ionization spectroscopy, was m/z 262.
Volkensiflavone (7): The UV (MeOH) absorption was max 215, 288 and 323 nm. The
molecular weight obtained, by negative electrospray ionization spectroscopy, was m/z
540.
Fukugetin (8): The UV (MeOH) absorption was max 214, 289 and 329 nm. The
molecular weight obtained, by negative electrospray ionization spectroscopy, was m/z
556.
Compound (9): yellow oil; UV (MeOH) absorption was max 213, 230 and 280 nm; 1HNMR (300 MHz, acetone-d6) and

13

C-NMR (300 MHz, acetone-d6). See Table 3.1;

HRESIMS was m/z 619.3568 [M+H] + (calcd for C38H50O7, 618.3557).
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Figure 3.1. Previously known compounds identified in fruits of G. intermedia
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Table 3.1. NMR Data for compound 9 (in acetone-d6)


H HMBC

Position
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38

13

C
192
119.3
193
68.7
50.2
40.6
38
61.7
213
199
133.5
116.9
145.7
150
114.6
123.9
26.1
122
132.7
25.9
17.9
19.3
30.1
30.1
125.9
132.6
25.8
17.8
39.4
42.6
148.5
110.2
17.6
75.6
125.8
132.5
25.8
17.7

1

H

1.76 m
2, 1.97 m

7.19 d (1.8)
6.72 d (8.2)
7.06 dd (8.2, 1.8)
2.6
5.03
1.69 s
1.64 s
1.221 s
1.216 s
2.07
4.95
1.61 s
1.48 s
2.15, 1.90
2.80
4.90 brs, 4.76 brs
1.67
3.94
4.89
1.61 s
1.68 s

b
connectivities
7A, 29B

17AB
17AB
7B, 22, 23
7A, 7B, 22, 23
6, 24 AB, 29A
7A, 7B
7B, 17AB
12, 16
15
16
12, 15
12, 15, 16
12
20, 21
17AB, 20, 21
18, 21
18, 20
23
22
6, 7AB
27, 28
27, 28
28
27
7AB, 30
29A, 29B, 34
33
33
32B
29A, 32A, 32B, 33
37, 38
37, 38
38
37

a
Proton coupling constants are given in parentheses; carbon types were confirmed with
b
DEPT and edited-HSQC experiments. Protons correlating with carbon resonance.
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Figure 3.2. Proposed structure of new polyisoprenylated benzophenone 9
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Figure 3.3. 1H spectrum of compound 9 in CD3OD (300 MHz)
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Figure 3.4. 13C spectrum of compound 9 in CD3OD (300 MHz)
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A

B

C

Figure 3.3 13C spectrum 3-28-C in CD3OD

Figure 3.5. Spectra of compound 9 in CD3OD (300 MHz): A 13C spectrum B DEPT 135 C
DEPT 90
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Figure 3.6. HSQC spectrum of compound 9 in CD3OD (300 MHz)
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Figure 3.7. HMBC spectrum of compound 9 in CD3OD (300 MHz)
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Chapter 4
Quantitative HPLC-PDA Analysis of Benzophenones and Biflavonoids in Eight
Garcinia Species
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4.1. Introduction
Fruits and vegetables are rich in essential antioxidant nutrients, including the provitamin -carotene and vitamins C and E. Additional antioxidants, such as polyphenols
ingested through the daily diet increase the antioxidant capacity of plasma1 and are an
important source of compounds protective against the damaging effects of free-radicals2.
The benefits of certain non-nutritional antioxidants such as flavonoids have been
evaluated in several epidemiological studies.3, 4, 5 In particular, it has been shown that a
diet rich in fruits and vegetables significantly reduces the incidence and mortality rate of
cardiovascular diseases,6 and a high intake of fruit and vegetables has protective effects
against cancer.7, 8
The Garcinia fruits are used frequently as food and sold in local markets in the
tropics. Garcinia mangostana L., native to Southeast Asia and commonly called
“mangosteen” and the “queen of fruits”,92 is highly regarded among connoisseurs who
consider it as one of the best tasting fruits.89 Mangosteen has been marketed to consumers
as a “superfruit” with health-beneficial effects in functional food and in dietary
supplements.93 The nonedible pericarp of G. mangostana has been used in Thai
traditional medicine to treat wounds, ulcers and dysentery.94 The fruit of G.
xanthochymus Hook. f. or “gamboge“ are native to India and is used in traditional
medicine for treating diarrhea and dysentery.25 The fruit is traditionally used as jellies or
preserve, as a tamarind substitute in cooking and as a yellow dye for fabric and
watercolors. Similarly, the fruits of G. spicata Hook.f. are native to South India and are
traditionally used to dye silk.95 The fruit of G. livingstonei T. Anderson is also called
“imbe” and is native to East Africa. It is widely distributed from Durban in South Africa
to Somalia and near the valleys of the Zambezi and Limpopo rivers.96,97 Garcinia
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intermedia (Pittier) Hammel is the only species of the genus native to Central America.
The fruits are used for jellies and preserves.89 The fruits are acidic and have two to three
seeds. The fruits of G. hombroniana Pierre are native to Malaysia, commonly called
“seashore mangosteen” and are the closest relative of “mangosteen”.12 Garcinia kola
Heckel is traditionally used by Western African healers, and is commonly used in West
Africa as a chewing stick to maintain dental health.98,99 The fruits of Garcinia aristata
Borhidi, native to Cuba, are also called the “Cuban mangosteen”, and have been found
growing in endangered habitats.64 Garcinia species display a high diversity of floral
morphology which led to the recognition of several segregated genera; however, a recent
taxonomic revision and a phylogenetic studies support a broad circumscription of
Garcinia, including the earlier segregated genera Ochrocarpus Thouars, Pentaphalagium
Warb., Rheedia L., and Tripetalum Schumann.12
In contrast to polyphenols, which are common in edible fruits from a large
number of plant families, the production of polyisoprenylated benzophenones and
xanthones is more restricted to families such as Clusiaceae and the Moraceae. In this
work the distribution of these constituents is analyzed in fruits of eight species of
Garcinia by high-performance liquid chromatography with a photo-diode array detector
(HPLC-PDA). Antioxidant properties and DPPH activity were tested, and the total
phenolic content (TPC) was determined by the Folin-Ciocalteau assay. This is the largest
comparative study of benzophenones and biflavonoids in eight Garcinia species.
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4. 2. Materials and methods
4.2.1. Chemicals
The purity of the standards (Fig. 4.1) was determined by HPLC and the following
values were obtained, xanthochymol = 78.8%, guttiferone E = 79.7%, guttiferone A =
96.0%, fukugetin = 100%, volkensiflavone = 100%, amentoflavone = 99.3%, and
fukugeside = 98.1%. The standards, guttiferone E, xanthochymol, guttiferone A,
volkensiflavone, fukugetin, and fukugeside (Fig. 4.1) have been previously isolated and
identified.25 The standard amentoflavone was purchased from ChromaDex (Santa Ana,
CA). Ammonium acetate was obtained from Sigma Aldrich. HPLC grade methanol and
acetonitrile solvents were obtained from J.T. Baker (Philipsburg, NJ).

Buffer was

prepared using, deionized water.
4.2.2. Plants
Fruits of G. xanthochymus, G. spicata, G. hombroniana, G. aristata, and G. intermedia
were collected by Margaret J. Basile at the Rare Fruit and Vegetable Council of Broward
County (FL) and the Fruit and Spice Park (Homestead, FL). The fruits were shipped
overnight on dry ice and frozen, and stored at - 20 ºC in the laboratory until extraction.
Voucher specimens were prepared and were deposited at the Lynda Steere Herbarium at
the New York Botanical Garden (Bronx, NY). The fruits of G. mangostana were
purchased in New York City. The chewing sticks of G. kola were a donation from the
Lewis’ collection and had been purchased from local markets in Cameroon.
4.2.3. Methods
Separation and identification were achieved using a Waters 2695 separation
module (Milford, MA) and a 2996 photodiode array detector operated with Empower
software. Separation was carried out on a Phenomenex Synergi® Hydro RP-18 column
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(250 x 2.00 mm id, 4 µm) (Torrance, CA) using a mobile phase and solvent system
composed of 10 mM ammonium acetate buffer (A) and acetonitrile (B) at a flow rate of
0.2 ml / min, and a temperature of 30 º C. The gradient profile consisted of three periods
(0 - 15 min) 25 - 30 % B; (15 - 30 min) 30 - 51 % B; (30 - 100 min) 51 B %, maintaining
isocratic conditions for the last period. Prior to the next sample injection, the column was
washed with 100 % B for 10 min before being equilibrated at the initial conditions for 15
minutes. The UVvis spectra were measured from 200 nm to 500 nm. Chromatograms
were extracted at max = 280 nm. A sample of 2 l was injected into the column in
triplicate (Fig. 4.2). The retention times are presented in Table 4.1. Limits of detection
(LOD) were determined based on a signal-to-noise ratio of 3:1. The limits of detection
was 260 ng/ml for amentoflavone and 330 ng/ml for guttiferone A (Table 4.1).
4.2.4. Standard dilutions
Stock solutions were prepared by dissolving individual standards in HPLC grade
MeOH. The concentrations were xanthochymol, 3.4 mg/ml; guttiferone E, 2.2 mg/ml; 7.2
mg/ml for guttiferone A; 2.7 mg/ml for volkensiflavone; 10.1 mg/ml for fukugetin; 6.5
mg/ml for amentoflavone and 12.7 mg/ml for fukugeside. Stock solutions were then
diluted with MeOH to provide ten concentration levels to determine the standard
calibration curves. The samples were filtered using Phenex RC 0.45 m membrane filter
(Millipore, Germany) and injected in triplicate into the HPLC.
4.2.5. Sample preparation
The fruits (10.00 g) were lyophilized and dried before being extracted three times
in 200 ml MeOH for 1 hour at room temperature. The extracts were then dried in vacuo at
40 ºC and then dissolved to 100 ml in a volumetric flask. Aliquots of 2 ml were stored for
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each extract in the freezer at – 20º C before HPLC analysis. Samples were filtered
through 0.45 m membrane filters, before injection into the HPLC.
4.2.6. Validation
Recovery tests were performed according to American Association of Analytical
Chemists guidelines for single laboratory validation (Section 3.3.2). Accuracy of the
method was achieved by determination of the recovery through standard addition. Three
different concentrations of amentoflavone (3.1, 1.5, and 0.8 mg/ml) were used to spike
0.50 g of lyophilized G. spicata fruit. Three different concentrations of guttiferone A
(6.8, 3.4, and 1.7 mg/ml) were used to spike 0.50 g of lyophilized G. spicata fruit. The
recoveries were determined by subtracting the values obtained from the control (unspiked
matrix) from the sample containing added spiked standard, divided by the amounts
added. Recovery was 96.2%, 98.7%, and 113.0% for amentoflavone, and for guttiferone
A recovery was 96.1%, 98.3%, and 98.7%. Guttiferone A was added at three levels,
150%, 70%, and 30%. The obtained values indicated that MeOH is an acceptable
extraction solvent.
4.2.7. Precision
The spiked samples were injected three times and the relative standard deviation
values (RSD %) were calculated for the peak area and were considered as a measure of
precision. The relative standard deviations (RSD %) from the recovery experiments
ranged from 0.07 % - 0.59 %.
4.2.8. DPPH assay
The DPPH antioxidant assay was performed according to procedures described by
Smith et al.91 Samples for the experiments (10 mg) were dissolved in 6 ml
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dimethylsulfoxide (DMSO) and further diluted to appropriate concentrations (15.6, 31.3,
62.5, 125, and 250 g/ml) before being transferred to a 96-well microtiter plate. The
experiments were performed in duplicate. Each well contained 150 l ethanolic solution
of DPPH (400 M) and 50 l of sample solution. Controls were prepared with 150 l
ethanol and DMSO. The microtiter plates were incubated at 37 C for 30 min and the
absorbance was measured at 515 nm using a microplate reader (Molecular Devices
Versamax). In the experiments, the negative controls, ethanol and DMSO, showed no
antioxidant activity. Ascorbic acid was used as a positive control. Percent inhibition by
sample exposure was determined by comparison with a DMSO-treated control group.
4.2.9. Total phenolic content
The aliquots of the extracted fruits were used for testing the total phenolic content
present in samples. A sample of 100 l of was added to 1 ml of 10% (v/v) FolinCiocalteau reagent incubated for 5 minutes and then 1 ml of 10% NaCO3 was added. The
mixture was incubated for 90 minutes before reading absorbance at 765 nm using a
microplate reader (Molecular Devices Versamax). All aliquots of analyzed samples and
gallic acid standards were analyzed in triplicate. Gallic acid equivalents (GAE) were
established for 1 gram of dry fruit.
4.2.10. Statistical analysis
Values are averages of three determinations and the standard deviation. The
results were analyzed for variation (ANOVA) and statistical significance by TukeyKramers test. Software JMP version 8 was used for data analysis. Pearson´s correlation
coefficient was calculated for DPPH activity.

69
4.3. Results and discussion
In our quest to identify novel sources of antioxidant from uncommonly used
edible plants, extracts of Garcinia species were investigated for their composition and
antioxidant properties for the first time, and compared to the well-known related species
G. mangostana.
The antioxidant activity of seven Garcinia fruits and the wood of G. kola were
tested using the DPPH scavenging assay (Table 4.2). The antioxidant activity of Garcinia
extracts was in the following order G. intermedia (IC50= 60.1  27.3 g/ml), and G.
mangostana (IC50= 64.3  11.3 g/ml)  G. livingstonei (IC50= 108.4  12.9 g/ml),
Garcinia hombroniana (IC50= 116.8  66.8 g/ml), G. aristata (IC50= 128.9  13.6
g/ml), and G. xanthochymus (IC50= 152.7  12.1 g/ml)  G. kola (IC50= 205.1  38.8
g/ml)  G. spicata (IC50= 185.3  20.9 g/ml) (Table 4.2). The scavenging activities
displayed by G. intermedia and G. mangostana were significantly higher than the other
tested Garcinia extracts.
The total phenolic content (TPC) Garcinia extracts was assessed using the FolinCiocalteau method, and the results are shown in Table 4.2. The TPC decreased in the
following order G. intermedia (476.9  40.8 GAE per g dry fruit)  G. hombroniana
(326.9  8.1 GAE per g of dry fruit), G. xanthochymus (283.6  65.3 GAE per g of dry
fruit), G. mangostana (263.3  6.4 GAE per g of dry fruit), G. kola (248.3  48.7 GAE
per g dry fruit), G. spicata (237.6  15.6 GAE per g of dry fruit), and G. aristata (237.1
 6.3 GAE per g of dry fruit)  G. livingstonei (115.5  34.1 GAE per g of dry fruit).
Garcinia intermedia has the highest amount of TPC compared to other Garcinia extracts.
Multivariate analysis did not show any correlation between TPC and antioxidant activity
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(r = -0.39), indicating that compounds other than the seven polyphenols quantified,
contribute significantly to antioxidant activity.100 However, there was significant
correlation between the contents of guttiferone A and TPC (r = 0.78).
This is the first study in which both benzophenones and biflavonoids are
quantified simultaneously in eight Garcinia species. The amounts of benzophenones and
biflavonoids were quantified by HPLC-PDA and a good linearity was achieved over the
concentration range presented, the seven calibration curves exhibited linear regressions of
at least R20.966. The limits of detection (LOD) and of quantitation (LOQ) were
determined under the operational conditions of the method (Table 4.1).
Polyisoprenylated benzophenones were present in the fruits of G. spicata, G.
xanthochymus, G. intermedia, G. livingstonei, and G. aristata. The amounts in mg/g of
dry fruit of polyisoprenylated benzophenones and biflavonoid in seven Garcinia species
are presented in Table 4.3. The content of xanthochymol decreased in the following order
G. spicata (70.50  1.10 mg/ g dry weight)  G. xanthochymus (65.10  0.03 mg/g dry
weight)  G. intermedia (2.90  0.20 mg/g dry weight). Previous studies quantifying
xanthochymol, found 35.60  3.60 mg/g of present in fruits of G. indica.101 The amount
of guttiferone E decreased in the following order, G. spicata (50.00  2.10 mg/g dry
weight) and G. xantochymus (48.10  2.60 mg/g dry weight)  G. intermedia (3.50 
0.20 mg/g dry weight). The content of guttiferone A decreased in the following order in
the fruits; G. intermedia (43.00  0.30 mg/g dry weight)  G. aristata (31.30 0.30 mg/g
dry weight)  G. livingstonei (11.20 0.50 mg/g dry weight)  G. spicata (4.80  0.07
mg/g dry weight). High amounts of guttiferone A in Garcinia fruits correlate with high
levels of DPPH activity (r= -0.79).
Among the biflavonoids analyzed, fukugetin decreased in the following order:
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G. xanthochymus (12.90  0.70 mg/g dry weight)  G. spicata (4.90  0.20 mg/g dry
weight)  G. intermedia (4.60  0.04 mg/g dry weight)  G. livingstonei (2.90  0.10
mg/g dry weight). The content of volkensiflavone decreased in the following order G.
hombroniana (12.40  0.20 mg/g dry weight)  G. kola (5.60  0.10 mg/g dry weight) 
G. xanthochymus (1.50  0.01 mg/g dry weight)  G. intermedia (0.90  0.08 mg/g dry
weight) and G. livingstonei (0.80  0.10 mg/g dry weight). The content of fukugeside
decreased in the following order G. xanthochymus (9.90  0.60 mg/g dry weight)  G.
spicata (5.40  0.10 mg/g dry weight)  G. intermedia (3.20  0.20 mg/g dry weight  G.
livingstonei (1.10  0.06 mg/g dry weight). The content of amentoflavone decreased in
the following order G. spicata (0.30  0.10 mg/g dry weight)  G. livingstonei (0.20 
0.03 mg/g dry weight)  G. xanthochymus (0.10  0.01 mg/g dry weight).
Garcinia spicata contained all the seven phytochemical constituents. Four
biflavonoids were detected in each of the following species: Garcinia livingstonei, G.
xanthochymus, and G. spicata. Biflavonoids are known for anti-inflammatory and
analgesic effects.102 Garcinia intermedia showed the presence of xanthochymol and
gutiferone E, although guttiferone A is the major constituent present in the fruit.
Garcinia mangostana and G. hombroniana show significant differences from the
other tested Garcinia species in their phytochemistry (lacking polyisoprenylated
benzophenones in their fruits), morphology (having hard rinds), and biogeography (both
native to Southeast Asia). These differences are in agreement with Sweeney, who divides
the genus Garcinia into two phylogenetic lineages, namely A (containing G. spicata, G.
kola, G. intermedia, and G. livingstonei) and B (containing G. mangostana and G.
hombroniana) based on morphology and genetic variation.12 Based on our limited sample
set, lineage A produces polyprenylated benzophenones, whereas lineage B does not,
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instead making the related compounds xanthones. However, the phytochemistry of
additional species in lineages A and B needs to be tested for this hypothesis to be
confirmed. In addition, the role of environmental factors on Garcinia fruits has not been
considered in this study.
In previous studies we have found that guttiferone E displays a higher activity
than its double-bond isomer xanthochymol against colon cancer.25 In this study the
separation between the double bond isomers was only achieved on a reversed-phase C18
column using a long run-time with a mobile phase composed of ammonium acetate
buffer and acetonitrile. This led to a total run time of 100 min. The selectivity factor α for
the adjacent bands of the pair of double bond isomers was  = 1.03 for guttiferone E, and
xanthochymol, but the resolution required isocratic conditions of 49 % A and 51 % B for
70 min. Separation of the structurally related double-bond isomers, guttiferone E and
xanthochymol was achieved. The only difference is that guttiferone E has a double bond
between carbon C-32 and C-33, while xanthochymol has a terminal double bond between
carbon C-33 and C-34 (Fig. 4.1). Thus the only structural difference is the sp - 2
hybridization on C-32 and C-34. Separation of closely related olefinic isomers is
challenging and different stationary phases for separation and improvement of the
resolution of olefinic isomers of estrogens have previously been evaluated.103 Low
retention time was achieved for early eluting fukugeside and the biflavonoids. The
compounds were identified based on retention time and UV absorbance in comparison
with individual standards. The seven peaks were identified based on the UV data and
absorbance spectra characteristic of polyisoprenylated benzophenones and biflavonoids.
The chromatographic method worked for the eight analyzed extracts.
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Dietary supplements containing G. mangostana are increasingly marketed to
consumers with claims of potential health beneficial effects; however, these claims need
to be clinically evaluated.104 The major constituent present in G. mangostana is mangostin.93 A recent study has shown that the human plasma antioxidant capacity
increases after one oral dose of mangosteen product. The bioavailablity of -mangostin
reaches its maximum concentration in plasma (Cmax) 3.12 1.47 ng /ml at tmax of 1 h after
consumption of mangosteen dietary product.105
Previous studies have shown that G. mangostana is a rich source of xanthones,
anthocyanins, and oligomeric proanthocyanidins.92 New xanthone compounds have been
isolated from G. mangostana.106 Polyisoprenylated benzophenones were detected in the
stem bark and heartwood of G. mangostana.

107,108

Studies in vitro have shown that the

isolated compounds from G. mangostana display antioxidant, anti-inflammatory,
antimicrobial, and cytotoxic activity.104 A crude methanolic extract showed
antiproliferative effects

104

and recent studies suggest that -mangostin is a potential

cancer chemopreventive compound.106 Toxicity studies in mice have shown that orally
administered G. mangostana extract showed LD50 = 9.37 g/kg weight.109
Garcinia species may be important in the prevention and/or treatment of cancer.15
For example, G. xanthochymus has shown activity against colon cancer cells.25 There is
evidence that suggests that polyisoprenylated benzophenones induce apoptosis and arrest
the cell cycle early in G1 phase, and prevent the transcription and translation of important
cell-cycle regulators involved in cell progression in cancerous cells.38 Thus they arrest the
cell cycle and interrupt cell division and inhibit the growth of cancer cells, up-regulating
mediators in the ER stress pathway.38 The mechanism of action and cellular pathways
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through which the benzophenones exert chemopreventive effects is still under
investigation.
Conclusions
The fruit of G. intermedia has significantly higher antioxidant capacity and total
phenolic content than the “superfruit” G. mangostana. Therefore, a new source of
antioxidants has been identified, which might be of great potential to human health.
However, further biological studies on the safety and efficacy of the fruit are warranted.
The fruits of G. spicata and G. xanthochymus contain the highest amounts of guttiferone
E and xanthochymol. These polyisoprenylated benzophenones are reported to have
chemopreventive effects against the early stages of carcinogenesis and thus have health
beneficial effects. The HPLC-PDA method used for identification and quantification of
polyisoprenylated benzophenones and biflavonoids was sensitive, reproducible and fully
validated.
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Figure 4.1. Polyisoprenylated benzophenones and biflavonoids quantified in the fruits of seven Garcinia species in this study.
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Figure 4.2. Chromatograms of eight Garcinia extracts analyzed at 280 nm. (1) Fukugeside (2) Fukugetin (3)
Amentoflavone (4) Volkensiflavone (5) Guttiferone A (6) Xanthochymol (7) Guttiferone E.
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Table 4.1. Concentration range of analyzed standards, equations of the calibration curves and linear regression coefficients.
Analytes
Fukugeside (1)
Fukugetin (2)
Amentoflavone (3)
Volkensiflavone (4)
Guttiferone A (5)
Xanthochymol (6)
Guttiferone E (7)

tR, (min)
6
17
20
28
53
90
93

UV data (, nm)
256, 329
288, 327
212, 292
212, 292, 328
229, 280
233, 279
229, 279

Linear regression data
Regressive equation
y =107x+355580
y =2x107x-106
y =2x107x +458366
y =2x107x+456891
y =107x+870060
y =3x106x+340315
y=3x107x+108058

Test range (g ml-1)
24.9-1.3x105
19.6-1.0x105
12.6-6.5x103
2.6-2.7x103
14.0-7.2x103
6.5-3.4x103
6.6-2.2x103

R2
1.000
0.999
0.999
0.998
0.998
0.966
0.998

LOD (ng ml-1)
720
109
260
337
330
707
482

LOQ (ng ml-1)
2397
363
867
1124
1100
2357
1607
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Table 4.2. DPPH activitya and total phenolic contenta (TPC) in eight Garcinia species

a

Sample

DPPH (g/ml)

TPC (GAE/g)

G. mangostana
G. hombroniana
G. livingstonei
G. xanthochymus
G. intermedia
G. aristata
G. spicata
G. kola

64.311.3a
116.866.8ab
108.412.9ab
152.712.1ab
60.127.3a
128.913.6ab
185.320.9c
205.138.8b

263.36.4a
326.98.1a
115.534.1b
283.665.3a
476.8740.8c
237.16.3a
237.615.6a
248.348.7a

Values are expressed as means  SD of three replicate analysis.
Means in the same column with different letters are not significantly different (p 0.05)

Table 4.3. Benzophenones and biflavonoids (mg/gram of dry weight) contents of eight Garcinia fruits and G.kola wood species.a

Fukugeside (1)

Fukugetin (2)

Amentoflavone (3)

Volkensiflavone (4)

Guttiferone A (5)

Xanthochymol (6)

Guttiferone E (7)

G. spicata

5.40±0.10a

4.90±0.20a

0.30±0.10a

0.40±0.01a

4.80±0.07a

70.50±1.10a

50.00±2.10a

G. xanthochymus

9.90±0.60b

12.90±0.70b

0.10±0.01b

1.50±0.01b

nd

65.10±0.03b

48.10±2.60a

G. intermedia

3.20±0.20c

4.60±0.04c

nd

0.90±0.08c

43.00±0.30b

2.90±0.20c

3.50±0.20b

G. livingstonei

1.10±0.06d

2.90±0.10d

0.20±0.03a

0.80±0.10c

11.20±0.50c

nd

nd

G. aristata

nd

nd

nd

nd

31.30±0.30d

nd

nd

G. hombroniana

nd

nd

nd

12.40±0.20d

nd

nd

nd

G. kola

nd

nd

nd

5.60±0.10e

nd

nd

nd

G. mangostana

nd

nd

nd

nd

nd

nd

nd

a

Values are expressed as means  SD of three replicate analysis. Means in the same column with different letters are significantly
different (p 0.05)
nd= not detected
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Chapter 5
Conclusions
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By high performance liquid chromatography photo-diode array (HPLC-PDA) we
have quantified the amounts of three major bioactive benzophenones, guttiferone A,
guttiferone E, and xanthochymol, in seven species of Garcinia fruits, including the
“superfruit” Garcinia mangostana. In addition, four biflavonoids were quantified:
amentoflavone, fukugeside, fukugetin, and volkensiflavone. The quantitative HPLC
method was validated with respect to linearity, accuracy, recovery, and precision. The
amounts of benzophenones and biflavonoids were quantified by HPLC-PDA and a good
linearity was achieved over the concentration range presented, the seven calibration
curves exhibited linear regressions of at least R2  0.966. The limit of detection LOD was
determined. The antioxidant activity of the Garcinia fruits and the wood of G. kola were
tested. The highest antioxidant activity was displayed by G. intermedia (IC50= 60.1 
27.3 g/ml) and G. mangostana (IC50= 64.3  27.3 g/ml). In comparison, the wood of
G. kola showed the lowest antioxidant activity (IC50=205.1  38.8 g/ml) in this study.
The total phenolic content was 476.9  40.8 GAE per gram dry fruit for G.
intermedia. This value was followed by followed by G. hombroniana which showed a
TPC of 326.9  8.1 GAE per gram of dry fruit. “The superfruit” G. mangostana had a
TPC of 263.3  6.4 GAE per gram of dry fruit. G. kola had 248.3  48.7 GAE per gram
of dry fruit. We have found that the tropical fruits of G. intermedia, G. mangostana, and
G. hombroniana display high antioxidant activity and contain a high level of total
phenolic compounds. The highest amounts of guttiferone E and xanthochymol were
found in both G. spicata and G. xanthochymol. Highest amount of guttiferone E was
found in G. spicata (50.0  2.1 mg/g dry weight). In this study xanthochymol was present
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in three of the analyzed fruits and quantified. The highest amount was detected in G.
spicata (70.5  1.1 mg/g dry weight). Guttiferone A was found at the highest levels in G.
intermedia (43.0  0.3 mg/g dry weight), followed by G. aristata (31.3  0.3 mg/g dry
weight), while the lowest levels of guttiferone A were observed in G. livingstonei (11.2 
0.5 mg/g dry weight).
We have found that the fruits of G. intermedia (IC50= 60.1  27.3 g/ml) have
higher antioxidant capacity than G. mangostana (IC50= 64.3  11.3 g/ml) and thus we
have identified a new sustainable source of compounds with higher antioxidant activity
than the “superfruit” mangosteen.
Overall the chemical profile and the content of polyisoprenylated benzophenones
are different among species of Garcinia fruits. The fruits with a hard pericarp do not
show the presence of polyisoprenylated benzophenones. Both the fruit extracts of G.
mangostana and G. intermedia, displayed high content of total phenolic content and high
antioxidant capacity. Noteworthy is the fact that the Central American species G.
intermedia showed higher antioxidant activity than the “superfruit” G. mangostana.
In the fruits of Garcinia intermedia the following known compounds were
identified: guttiferone A, guttiferone E, isoxanthochymol, xanthochymol, aristophenone,
maclurin, fukugetin, and volkensiflavone. One new benzophenone isomer of m/z 618 was
isolated and tentatively identified using 1D and 2D NMR experiments.
The antioxidant activity for guttiferone A (IC50= 46 µM) is comparable to gallic
acid (IC50= 35 µM). Guttiferone A, a major constituent in G. intermedia, showed
antiproliferative effects (9 µg/ml). Further it did not only enhance the effects of the
chemopreventive agent sulindac sulfide against colon cancer HT-29 cells but also showed
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strong synergistic activity in combination with the chemopreventive agent. Guttiferone A
is a possible new lead compound for a potentially new chemopreventive agent of colon
cancer.
Many new polyisoprenylated benzophenones with a bicyclo[3.3.1]-nonane-2,4,9trione core structure have been isolated from plants in the Clusiaceae family, and their
potent biological properties have been the subject of several studies. The cellular target
through which guttiferone A exerts antiproliferative effects, and interrupts the cell cycle
of cancer cells, needs to be investigated. The target of guttiferone A in colon caner cells
needs to be identified, in order to be able to produce effective benzophenone analogues
for chemoprevention. It is possible that guttiferone A affects the inflammatory mediation
during the initiation of carcinogenesis, having an effect on the inducible enzymes iNOS
and COX-2. This may be the mechanism of action through which polyisoprenylated
benzophenones exert their antiproliferative effects in vitro. Evidence presented by
independent investigators suggests that polyisoprenylated benzophenones affect the
mediators in the Akt/mTOR stress pathway, although the specific target remains to be
discovered. In addition, benzophenones isolated from plants display high antioxidant
capacity and protect cells from oxidative stress, and the formation of ROS involved
during the inflammatory process.
There is clinical evidence suggesting that breast cancer can be prevented in
women with relative high risk of developing the disease, by means of pharmacological
treatment and chemoprevention.110 This shows that pharmacologic treatment, with the
purpose of arresting and/or reversing the process of carcinogenesis, is a potential
alternative for future efficient prevention of cancer.

111

During the early stages of colon
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carcinogenesis there is over-expression of the cyclooxygenase-2 (COX-2). The mediators
in the inflammatory response are up regulated in the initial stages of carcinogenesis in
colon cancer cells. It is possible that guttiferone A also suppresses the inflammatory
response during the initiation of carcinogenesis.
New approaches to control the disease are critically needed, and the prevention of
the initiation of cancerogenesis is essential for the reduction in the incidence of the
disease. New classes of compounds with chemopreventive effects, with the potential of
being developed into lead compounds to prevent cancer are needed for future efficacious
pharmacological treatment. Moreover, the discovery of a putative target might lead to
more effective treatments against cancer, and possibly find an alternative approach
through which cancer can be prevented.
Fruits of Garcinia plants are a rich dietary source of phenolic compounds. These
findings suggest that fruits of G. intermedia which are rich in guttiferone A, might
prevent colon cancer, and that the consumption of the fruit might have potential
chemopreventive effects. Garcinia fruits are a rich dietary source of new phenolic
compounds, particularly polyisoprenylated benzophenones high in antioxidant capacity.
The polyisoprenylated benzophenones might prevent the damaging effects of free
radicals involved in the etiology of atherosclerosis and other inflammatory processes. In
addition, these compounds have shown antiproliferative effects. The phenolic compounds
in Garcinia fruits have antioxidant activity and antiproliferative effects and may possibly
prevent certain types of cancer.
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